WO2014115834A1 - Azolyl oxime compound or salt thereof, pest-control agent, insecticide or acaricide, disinfectant, and external parasite control agent - Google Patents

Azolyl oxime compound or salt thereof, pest-control agent, insecticide or acaricide, disinfectant, and external parasite control agent Download PDF

Info

Publication number
WO2014115834A1
WO2014115834A1 PCT/JP2014/051486 JP2014051486W WO2014115834A1 WO 2014115834 A1 WO2014115834 A1 WO 2014115834A1 JP 2014051486 W JP2014051486 W JP 2014051486W WO 2014115834 A1 WO2014115834 A1 WO 2014115834A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
unsubstituted
substituted
salt
compound
Prior art date
Application number
PCT/JP2014/051486
Other languages
French (fr)
Japanese (ja)
Inventor
衆一 伊藤
純司 一法師
睦大 天野
岩田 淳
伸哉 幸堀
里枝 坂本
Original Assignee
日本曹達株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本曹達株式会社 filed Critical 日本曹達株式会社
Publication of WO2014115834A1 publication Critical patent/WO2014115834A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/713Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Definitions

  • the present invention relates to azolyl oxime compounds, pest control agents, insecticides or acaricides, fungicides, and ectoparasite control agents. More specifically, the present invention relates to an azolyloxime compound or a salt thereof, which has excellent insecticidal activity and / or acaricidal activity, is excellent in safety, and can be advantageously synthesized industrially, and harmful substances containing this as an active ingredient. The present invention relates to biocontrol agents, insecticides or acaricides, fungicides, and ectoparasite control agents. This application claims priority based on Japanese Patent Application No. 2013-012989 filed in Japan on January 28, 2013, the contents of which are incorporated herein by reference.
  • Patent Document 1 discloses an azolyl oxime compound having naphthyl or pyridyl and triazolyl or imidazolyl in the molecular structure. Patent Document 1 states that some of the compounds had an insecticidal effect against leafhopper, leafhopper, and diamondback moth. However, other compounds are merely described as potential insecticides.
  • Patent Document 2 discloses a pyridine derivative. An azolyl oxime compound is disclosed as one of the pyridine derivatives. Patent Document 2 states that some of the compounds had an insecticidal effect against peach aphid, brown planthopper, silver leaf whitefly, and the like. However, other compounds are merely described as potential insecticides.
  • “Azolyl” is a 5-membered saturated or unsaturated heterocyclyl group having two or more hetero atoms selected from the group consisting of a nitrogen atom, a sulfur atom and an oxygen atom as ring member atoms, and at least one of the hetero atoms.
  • One is a nitrogen atom.
  • Specific examples include triazolyl and imidazolyl.
  • An object of the present invention is to provide an azolyl oxime compound or a salt thereof, which is excellent in pest control activity, in particular, insecticidal activity and / or acaricidal activity, is excellent in safety, and can be synthesized advantageously industrially, and It is to provide a pest control agent containing an active ingredient as an active ingredient, and an insecticide or acaricide. Furthermore, it is providing the bactericidal agent containing this as an active ingredient, and an ectoparasite control agent.
  • an azolyloxime compound having a specific structure such as a diazine ring or a triazine ring or a salt thereof has excellent insecticidal activity and / or acaricidal activity, It was also found that it has good characteristics and high safety and can be used as an active ingredient of a pest control agent. Furthermore, it discovered that it could utilize as an active ingredient of a disinfectant and an ectoparasite control agent. The present invention has been completed based on this finding.
  • the present invention includes the following.
  • Het represents a 6-membered heteroaryl ring containing 2 to 3 nitrogen atoms as constituent atoms of the ring.
  • X 1 is a substituent on Het, which is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted C2-6 alkenyloxy Group, unsubstituted or substituted C2-6 alkynyloxy group, unsubstituted or substituted C3-8 cycloalkyloxy group, unsubstituted or substituted C1-7 acyl group, unsubstituted Or a substituted C1-6 alkoxycarbonyl group, an unsubstituted
  • X 1 may be the same as or different from each other.
  • A represents a carbon atom or a nitrogen atom.
  • X 2 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group A C1-6 alkoxycarbonyl group, an unsubstituted or substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfonyl group, Unsubstituted or substituted C6-10
  • n represents the number of X 2 and is an integer from 0 to 3. When n is 2 or more, X 2 may be the same as or different from each other.
  • R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted 3-6 membered heterocyclyl group is shown.
  • a bond represented by crossed solid lines represents a double bond having stereoisomerism.
  • X 11 represents an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl Group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted amino group, unsubstituted or substituted A C1-6 alkylthio group having a group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1-6 alkylsulfonyl group, a halogeno group, a cyano group, or a nitro group .
  • m1 represents the number of X 11 and is an integer from 0 to 2. When m1 is 2 or more, X 11 may be the same as or different from each other.
  • the bonds represented by X 1 , A, X 2 , n, R 1 and the crossed solid line are as described above.
  • a pest control agent comprising as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] and a salt thereof.
  • An insecticide or acaricide containing as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] and a salt thereof.
  • a bactericide containing as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] and a salt thereof.
  • An ectoparasite control agent comprising as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] above and a salt thereof.
  • the azolyloxime compound or a salt thereof of the present invention can control pests that are problematic in terms of crops and hygiene.
  • agricultural pests and mites can be effectively controlled.
  • plant diseases can be effectively controlled.
  • ectoparasites that harm human livestock can be effectively controlled.
  • the azolyloxime compound of the present invention is a compound represented by the formula (I) (hereinafter sometimes referred to as compound (I)).
  • the term “unsubstituted” means only a group serving as a mother nucleus. When there is no description of “having a substituent” and only the name of the group serving as a mother nucleus is used, it means “unsubstituted” unless otherwise specified.
  • the term “having a substituent” means that any hydrogen atom of a group serving as a mother nucleus is substituted with a group having the same or different structure from the mother nucleus. Accordingly, the “substituent” is another group bonded to a group serving as a mother nucleus.
  • the number of substituents may be one, or two or more. Two or more substituents may be the same or different.
  • C1-6 indicate that the group serving as the mother nucleus has 1 to 6 carbon atoms. This number of carbon atoms does not include the number of carbon atoms present in the substituent.
  • a butyl group having an ethoxy group as a substituent is classified as a C2 alkoxy C4 alkyl group.
  • the “substituent” is not particularly limited as long as it is chemically acceptable and has the effects of the present invention. Examples of groups that can be “substituents” are shown below. C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc.
  • An alkyl group Vinyl group, 1-propenyl group, 2-propenyl group (also known as allyl group), 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group
  • a C2-6 alkenyl group such as a group
  • C2-6 alkynyl groups such as ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group
  • a C3-8 cycloalkyl group such as a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group
  • a C4-8 cycloalkenyl group such as a
  • a C6-10 aryl group such as a phenyl group or a naphthyl group
  • a C6-10 aryl C1-6 alkyl group such as a benzyl group or a phenethyl group
  • 3-6 membered heterocyclyl group
  • a C1-7 acyl group such as a formyl group, an acetyl group, a propionyl group, a benzoyl group, a cyclohexylcarbonyl group
  • a hydroxy group such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group; C2-6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group, butenyloxy group; C2-6 alkynyloxy groups such as ethynyloxy group and propargyloxy group; C6-10 aryloxy groups such as phenoxy group and 1-naphthoxy group; A C6-10 aryl C1-6 alkoxy group such as a benzyloxy group or a phenethyloxy group; A 3-6 membered heterocyclyloxy group; A 3-6 membered heterocyclyl C1-6 alkoxy group;
  • C1-7 acyloxy groups such as formyloxy group, acetyloxy group, propionyloxy group, benzoyloxy group, cyclohexylcarbonyloxy group;
  • a C1-6 alkoxycarbonyl group such as a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, a t-butoxycarbonyl group; Carboxyl group;
  • Halogeno groups such as fluoro, chloro, bromo and iodo groups; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group; A C2-6 haloalkenyl group such as a 2-chloro-1-propenyl group and a 2-fluoro-1-butenyl group; A C2-6 haloalkynyl group such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group; C6-10 haloaryl group such as 4-chlorophenyl group, 4-fluorophenyl group, 2,4-dichlorophenyl group; A C1-6 haloalkoxy group such as a trifluorome
  • a C1-6 alkylamino group such as a methylamino group, a dimethylamino group, a diethylamino group
  • C6-10 arylamino groups such as anilino group and naphthylamino group
  • a C6-10 aryl C1-6 alkylamino group such as a benzylamino group or a phenethylamino group
  • C1-7 acylamino groups such as formylamino group, acetylamino group, propanoylamino group, butyrylamino group, i-propylcarbonylamino group, benzoylamino group
  • a C1-6 alkoxycarbonylamino group such as a methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group
  • An aminocarbonyl group having no substituent or a substituent such as an amino
  • a mercapto group such as methylthio group, ethylthio group, n-propylthio group, i-propylthio group, n-butylthio group, i-butylthio group, s-butylthio group, t-butylthio group;
  • a C6-10 arylthio group such as a phenylthio group or a naphthylthio group;
  • a C6-10 aryl C1-6 alkylthio group such as a benzylthio group or a phenethylthio group;
  • a C1-6 alkylsulfinyl group such as a methylsulfinyl group, an ethylsulfinyl group, a t-butylsulfinyl group;
  • a C6-10 arylsulfinyl group such as a phenylsulfinyl group;
  • a tri-C1-6 alkyl-substituted silyl group such as a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group; A triphenylsilyl group; Cyano group; nitro group;
  • any hydrogen atom in the substituent may be substituted with a group having a different structure.
  • the “3- to 6-membered heterocyclyl group” includes 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring constituent atoms.
  • the heterocyclyl group may be monocyclic or polycyclic. In the polycyclic heterocyclyl group, when at least one ring is heterocyclyl, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring.
  • Examples of the “3- to 6-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, and a 5- to 6-membered partially unsaturated heterocyclyl group.
  • Examples of the 3- to 6-membered saturated heterocyclyl group include aziridinyl group, oxiranyl group, azetidinyl group, oxetanyl group, pyrrolidinyl group, tetrahydrofuranyl group, thiazolidinyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, and dioxanyl group.
  • Examples of the 5-membered heteroaryl group include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, etc. .
  • Examples of the 6-membered heteroaryl group include a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridanidyl group, and a triazinyl group.
  • Het represents a 6-membered heteroaryl ring containing 2 to 3 nitrogen atoms as constituent atoms of the ring. Het is preferably a pyrimidine ring.
  • X 1 is a substituent on Het, which is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted C2-6 alkenyloxy Group, unsubstituted or substituted C2-6 alkynyloxy group, unsubstituted or substituted C3-8 cycloalkyloxy group, unsubstituted or substituted C1-7 acyl group, unsubstituted Or a substituted C1-6 alkoxycarbonyl group, an unsubstituted or substituted C1-6 alkylcarbamoyl group, unsubstituted Or a substituted amino group, a
  • the “C1-6 alkyl group” for X 1 may be linear or branched.
  • Examples of the alkyl group include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s-butyl group and t-butyl group.
  • examples of the substituent include a halogeno group, a C3-8 cycloalkyl group, a hydroxy group, a C1-6 alkoxy group, a C6-10 aryl group, a C1-7 acyl group, a C1 Up to 6 alkoxycarbonyl groups.
  • C1-6 alkyl group having a substituent include Fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, dichloromethyl group, dibromomethyl group, trifluoromethyl group, trichloromethyl group, tribromomethyl group, 2,2,2-trifluoroethyl group, 2, 2,2-trichloroethyl group, pentafluoroethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 3,3,3-trifluoropropyl group, 2,2,2-trifluoro-1-trifluoromethylethyl Group, perfluorohexyl group, perchlorohexyl group, 2,4,6-trichlorohexyl group, perfluoropropyl group, perfluorobutyl group, perfluoropentyl group, 3,3,4,4,5,5,5 -C1 ⁇ such as heptafluoropentyl group, 2,
  • Hydroxy C1-6 alkyl groups such as hydroxymethyl group, 2-hydroxyethyl group; Methoxymethyl group, ethoxymethyl group, methoxyethyl group, ethoxyethyl group, methoxy-n-propyl group, ethoxymethyl group, ethoxyethyl group, n-propoxymethyl group, i-propoxyethyl group, s-butoxymethyl group, t
  • a C1-6 alkoxy C1-6 alkyl group such as a butoxyethyl group
  • a C6-10 aryl C1-6 alkyl group such as a benzyl group or a phenethyl group
  • C1-7 acyl C1-6 alkyl group such as formylmethyl group, acetylmethyl group, propionylmethyl group
  • a C1-6 alkoxycarbonyl C1-6 alkyl group such as a methoxycarbonylmethyl group, an ethoxycarbonylmethyl group, an n-propoxy
  • Examples of the “C2-6 alkenyl group” for X 1 include a vinyl group, 1-propenyl group, 2-propenyl group (allyl group), 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2 -Propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
  • Examples of the “substituted C2-6 alkenyl group” include C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group.
  • Examples of the “C2-6 alkynyl group” in X 1 include ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl Group, 1,1-dimethyl-2-butynyl group and the like.
  • a C2-6 haloalkynyl group such as a 4,4-dichloro-1-butynyl group, a 4-fluoro-1-pentynyl group, a 5-bromo-2-pentynyl group, etc. Etc.
  • Examples of the “C3-8 cycloalkyl group” for X 1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and the like.
  • the “C1-6 alkoxy group” in X 1 is a methoxy group, ethoxy group, n-propoxy group, n-butoxy group, n-pentyloxy group, n-hexyloxy group, i-propoxy group, i-butoxy group , S-butoxy group, t-butoxy group, i-hexyloxy group, 3,3-dimethylbutoxy group, isopentyloxy group, neopentyloxy group, 2,3,3-trimethylbutoxy group, (4,4- And dimethylpentan-2-yl) oxy group.
  • examples of the substituent include a halogeno group, a C3-8 cycloalkyl group, a hydroxy group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C6-10 aryl group, 3-6 heterocyclyl group, C1-6 alkoxycarbonyl group, C1-6 alkyl substituted amino group, C1-6 alkylthio group, C1-6 alkylsulfinyl group, C1-6 alkylsulfonyl group, cyano group, C1-6 alkyl substituted silyl Groups and the like.
  • substituted C1-6 alkoxy group examples include chloromethoxy group, dichloromethoxy group, difluoromethoxy group, trichloromethoxy group, trifluoromethoxy group, 1-fluoroethoxy group, 1,1-difluoroethoxy.
  • C3-8 cycloalkyl C1-6 alkoxy groups such as cyclopropylmethoxy group, 2-cyclopropylethoxy group, cyclopentylmethoxy group, cyclohexylmethoxy group, 2-cyclohexylethoxy group; (2,2-difluorocyclopropyl) methoxy group, etc.
  • Hydroxy C1-6 alkoxy groups such as 3-hydroxy-3-methylbutoxy group
  • C1-6 alkoxy C1 such as 2-ethoxyethoxy group, 3-methoxy-3-methylbutoxy group, 2- (t-butoxy) ethoxy group -6 alkoxy group
  • C1-6 haloalkoxy C1-6 alkoxy group such as trifluoromethoxymethoxy group and trifluoromethoxyethoxy group
  • a C6-10 aryl C1-6 alkoxy group such as benzyloxy group, phenoxy group, 3-phenylpropoxy group; (4-methylbenzyl) oxy group, (4-methoxybenzyl) oxy group, (4-trifluorobenzyl) oxy group, (4-fluorobenzyl) oxy group, etc.
  • C1-6 alkoxycarbonyl such as 2- (ethoxycarbonyl) ethoxy group C1-6 alkoxy group; C1-6 such as (1- (dimethylamino) propan-2-yl) oxy group, 2- (dimethylamino) ethoxy group Alkyl substituted amino C1-6 alkoxy group; C1-6 alkylthio C1-6 alkoxy group such as 3- (methylthio) propoxy group; C1-6 alkylsulfinyl C1-6 alkoxy group such as 3- (methylsulfinyl) propoxy group; 3 A C1-6 alkylsulfonyl C1-6 alkoxy group such as a-(methylsulfonyl) propoxy group; a cyano C1-6 alkoxy group such as a 2-cyano-2-methylpropoxy group; a triC1-6 such as a 3- (trimethylsilyl) propoxy group 6 alkyl substituted silyl C1-6 alkoxy groups; It is.
  • Examples of the “C2-6 alkenyloxy group” in X 1 include a vinyloxy group, 1-propenyloxy group, 2-propenyloxy group (allyloxy group), (3-methylbut-2-en-1-yl) oxy group and the like. Can be mentioned.
  • Examples of the “substituted C2-6 alkenyloxy group” include (2,3,3-trifluoroallyl) oxy group, (3,4,4-trifluorobut-3-en-1-yl) oxy group C2-6 haloalkenyloxy groups such as; C6-C10 aryl C2-6 alkenyloxy groups such as (3-phenylallyl) oxy group; and the like.
  • Examples of the “C2-6 alkynyloxy group” for X 1 include ethynyloxy group, prop-2-yn-1-yloxy group, but-2-yn-1-yloxy group and the like.
  • Examples of the “substituted C2-6 alkynyloxy group” include C2 such as 4,4-dichloro-1-butynyloxy group, 4-fluoro-1-pentynyloxy group, 5-bromo-2-pentynyloxy group, etc.
  • C6-C10 aryl C2-6 alkynyloxy groups such as (3-phenylprop-2-yn-1-yl) oxy group;
  • Examples of the “C3-8 cycloalkyloxy group” for X 1 include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group, and the like.
  • Examples of the “substituted C3-8 cycloalkyloxy group” include C3-8 halocycloalkyloxy groups such as (4,4-difluorocyclohexyl) oxy group.
  • Examples of the “C1-7 acyl group” in X 1 include formyl group, acetyl group, propionyl group, benzoyl group and the like.
  • Examples of the “substituted C1-7 acyl group” include C1-7 haloacyl groups such as a chloroacetyl group, a trifluoroacetyl group, a trichloroacetyl group, and a 4-chlorobenzoyl group.
  • Examples of the “C1-6 alkoxycarbonyl group” for X 1 include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, and the like.
  • C1-6 alkylcarbamoyl group for X 1 include a methylcarbamoyl group, an ethylcarbamoyl group, and the like.
  • substituted C1-6 alkylcarbamoyl group include C1-6 haloalkylcarbamoyl groups such as a (2,2,2-trifluoroethyl) carbamoyl group.
  • a C1-6 alkyl-substituted amino group such as a methylamino group, a dimethylamino group, a diethylamino group, an isopentylamino group, an isopentyl (methyl) amino group; , 3,3,4,4,4-heptafluorobutyl) amino group and the like, and the like.
  • Examples of the “C1-6 alkylthio group” in X 1 include methylthio group, ethylthio group, n-propylthio group, n-butylthio group, n-pentylthio group, n-hexylthio group, i-propylthio group, isopentylthio group and the like. Can be mentioned.
  • Examples of the “C1-6 alkylsulfinyl group” in X 1 include a methylsulfinyl group, an ethylsulfinyl group, a t-butylsulfinyl group, and an isopentylsulfinyl group.
  • Examples of the “C1-6 alkylsulfonyl group” for X 1 include a methylsulfonyl group, an ethylsulfonyl group, a t-butylsulfonyl group, an isopentylsulfonyl group, and the like.
  • the “C6-10 aryl group” for X 1 may be monocyclic or polycyclic. In the polycyclic aryl group, if at least one ring is an aromatic ring, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the “C6-10 aryl group” include phenyl group, naphthyl group, azulenyl group, indenyl group, indanyl group, tetralinyl group and the like.
  • the “3- to 6-membered heterocyclyl group” in X 1 includes 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom, and a sulfur atom as ring constituent atoms.
  • the heterocyclyl group may be monocyclic or polycyclic. In the polycyclic heterocyclyl group, when at least one ring is heterocyclyl, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring.
  • Examples of the “3- to 6-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, and a 5- to 6-membered partially unsaturated heterocyclyl group.
  • Examples of the 3- to 6-membered saturated heterocyclyl group include aziridinyl group, oxiranyl group, azetidinyl group, oxetanyl group, pyrrolidinyl group, tetrahydrofuranyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, dioxanyl group and the like.
  • Examples of the 5-membered heteroaryl group include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, etc. .
  • Examples of the 6-membered heteroaryl group include a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridanidyl group, and a triazinyl group.
  • Examples of the partially unsaturated 5-membered heterocyclyl group include pyrrolinyl group, imidazolinyl group (dihydroimidazolinyl group), pyrazolinyl group, oxazolinyl group, isoxazolinyl group, thiazolinyl group and the like.
  • Examples of the partially unsaturated 6-membered heterocyclyl group include a thiopyranyl group, a 2H-pyridin-1-yl group, and a 4H-pyridin-1-yl group.
  • Substituents on “C6-10 aryl group” and “3-6 membered heterocyclyl group” include C1-6 alkyl group, hydroxy group, C1-6 alkoxy group, halogeno group, cyano group, nitro group, C1-6 And a haloalkyl group.
  • Examples of the “C6-10 aryloxy group” for X 1 include a phenoxy group and a 1-naphthoxy group.
  • Examples of the substituent on the “C6-10 aryloxy group” include a C1-6 alkyl group, a hydroxy group, a C1-6 alkoxy group, a halogeno group, a cyano group, a nitro group, and a C1-6 haloalkyl group.
  • halogeno group examples include a fluoro group, a chloro group, a bromo group, and an iodo group.
  • X 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, an unsubstituted Or a substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group C1-6 alkoxycarbonyl group, unsubstituted or substituted amino group, unsubstituted or substituted C1-6 alkylthio group, unsubstituted or substituted C1-6 alkylsulfonyl group, unsubstituted Or a substituted C6-10 aryl group, an unsubstituted or substituted 3-6 membered heterocyclyl group, a halo Amino group is preferably a cyano
  • X 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C2-6 alkenyloxy group, unsubstituted Or a substituted C2-6 alkynyloxy group, an unsubstituted or substituted C3-8 cycloalkyloxy group, an unsubstituted or substituted C1-6 alkylcarbamoyl group, an unsubstituted or substituted group An unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted 3-6 membered heterocyclyl group, or an unsubstituted or substituted C6-10 aryloxy group More preferably.
  • X 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-6 alkylthio group, or an unsubstituted group. Or a 3- to 6-membered saturated heterocyclyl group having a substituent.
  • the substituent is preferably a halogeno group or a C3-8 cycloalkyl group.
  • examples of the substituent include a C1-6 alkyl group, a hydroxy group, a C1-6 alkoxy group, a C1-6 alkylthio group, a C6-10 aryl group, and a 3-6 membered heterocyclyl.
  • Group, C1-6 alkyl 3-6 membered heterocyclyl group, halogeno group, cyano group, C3-8 cycloalkyl group, halo C3-8 cycloalkyl group, C1-6 alkyl C3-8 cycloalkyl group and the like are preferable.
  • the substituent is preferably a halogeno group or the like.
  • the substituent is preferably a C1-6 alkyl group and the like.
  • the substituent is preferably a C1-6 alkyl group, a halogeno group, a cyano group, a C1-6 haloalkyl group, or the like.
  • X 1 C1 ⁇ 6 alkyl group, C1 ⁇ 6 haloalkyl group, C1 ⁇ 6 alkoxy group, C1 ⁇ 6 haloalkoxy group, C3 ⁇ 8 cycloalkyl C1 ⁇ 6 alkoxy group, C1 ⁇ 6 alkylthio group, Or, it is preferably a 3- to 6-membered saturated heterocyclyl group.
  • A represents a carbon atom or a nitrogen atom.
  • A is preferably a nitrogen atom.
  • X 2 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group A C1-6 alkoxycarbonyl group, an unsubstituted or substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfonyl group, Unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl Shows a halogen
  • C1-6 alkyl group “C2-6 alkenyl group”, “C2-6 alkynyl group”, “C3-8 cycloalkyl group”, “C1-6 alkoxy group”, “C1-7 acyl group” for X 2 ”,“ C1-6 alkoxycarbonyl group ”,“ amino group ”,“ C1-6 alkylthio group ”,“ C1-6 alkylsulfonyl group ”,“ C6-10 aryl group ”,“ 3-6 membered heterocyclyl group ”, Examples of the “halogeno group” and the group having a substituent in these groups are the same as those exemplified for X 1 above.
  • R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted 3-6 membered heterocyclyl group is shown.
  • C1-6 alkyl group “C2-6 alkenyl group”, “C2-6 alkynyl group”, “C3-8 cycloalkyl group”, “C6-10 aryl group”, and “3-6 members” in R 1
  • R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, or an unsubstituted or substituted C2-6 alkynyl group. Is preferred.
  • the substituent is preferably a C3-8 cycloalkyl group or a halogeno group.
  • a bond represented by crossed solid lines represents a double bond having stereoisomerism (undefined double stereo bond).
  • the azolyl oxime compound of the present invention or a salt thereof has an E isomer or a Z isomer, or an E isomer, which is a stereoisomer of a double bond derived from the oxime structure in the formula (I). And a mixture of Z isomers.
  • the azolyl oxime compound of the present invention is preferably an azolyl oxime compound represented by formula (II) (hereinafter sometimes referred to as compound (II)).
  • formula (II) X 1 , A, X 2 , n, R 1 and the bond represented by the crossed solid line are as described above.
  • X 11 represents an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl Group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted amino group, unsubstituted or substituted A C1-6 alkylthio group having a group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1-6 alkylsulfonyl group, a halogeno group, a cyano group, or a nitro group .
  • m1 represents the number of X 11 and is an integer from 0 to 2. When m1 is 2 or more, X 11 may be the same as or
  • C1 ⁇ 6 alkyl group in X 11, "C2 ⁇ 6 alkenyl group”, “C2 ⁇ 6 alkynyl group”, “C3 ⁇ 8 cycloalkyl group”, “C1 ⁇ 6 alkoxy group”, "amino group”, “ “C1-6 alkylthio group”, “C1-6 alkylsulfinyl group”, “C1-6 alkylsulfonyl group”, “halogeno group” and groups having substituents on these groups include those exemplified in the above X 1 The same thing is mentioned.
  • X 11 is preferably an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-6 alkoxy group, or a halogeno group.
  • X 11 is more preferably a halogeno group or a cyano group.
  • m1 is preferably an integer of 0 or 1.
  • Examples of the azolyl oxime compound of the present invention include an azolyl oxime compound represented by the formula (III) (hereinafter sometimes referred to as compound (III)).
  • the salt of the azolyl oxime compound of the present invention is a salt of any of the compounds (I) to (III).
  • the salt is not particularly limited as long as it is an agro-horticulturally acceptable salt.
  • salts of inorganic acids such as hydrochloric acid and sulfuric acid
  • salts of organic acids such as acetic acid and lactic acid
  • salts of alkali metals such as lithium, sodium and potassium
  • salts of alkaline earth metals such as calcium and magnesium
  • iron and copper salts of organic bases such as ammonia, triethylamine, tributylamine, pyridine and hydrazine.
  • the salt of the azolyl oxime compound can be obtained by a known method.
  • the azolyloxime compound and the salt thereof of the present invention are not particularly limited by the production method.
  • the azolyl oxime compound and its salt of the present invention can be obtained by known production methods described in Examples and the like.
  • the azolyl oxime compound of the present invention or a salt thereof (hereinafter sometimes referred to as “the compound of the present invention”) has an excellent pest control effect such as various agricultural pests and mites that affect plant growth. In addition, it is a highly safe compound due to its low phytotoxicity and low toxicity to fish and warm-blooded animals. Therefore, it is useful as an active ingredient of an insecticide or an acaricide. Furthermore, in recent years, resistance to organophosphates and carbamates has been developed in many pests such as diamondback moth, leafhopper, leafhopper, and aphid, resulting in a lack of efficacy of these drugs. Is desired. The compound of the present invention exhibits an excellent control effect not only on susceptible strains but also on pests of various resistant strains, and further on mite-resistant strains of mites.
  • the compounds of the present invention can be used for a wide variety of filamentous fungi such as fungi belonging to algae (Oomycetes), Ascomycetes, Deuteromycetes, and basidiomycetes. Excellent control of plant pathogens. Therefore, it is useful as an active ingredient of a bactericide.
  • filamentous fungi such as fungi belonging to algae (Oomycetes), Ascomycetes, Deuteromycetes, and basidiomycetes. Excellent control of plant pathogens. Therefore, it is useful as an active ingredient of a bactericide.
  • the pest control agent of the present invention contains at least one selected from the compounds of the present invention as an active ingredient.
  • plants to be treated with the pest control agent of the present invention include cereals, vegetables, root vegetables, potatoes, trees, grasses, turf and the like. In that case, each part of these plants can also be processed.
  • each part of the plant include leaves, stems, patterns, flowers, buds, fruits, seeds, sprout, roots, tubers, tuberous roots, shoots, cuttings, and the like.
  • GMO genetically modified organisms
  • the pest control agent of the present invention can be used for seed treatment, foliage application, soil application, water surface application, etc. to control various agricultural pests and mites, and further to control various phytopathogenic fungi. it can.
  • the pest control agent of the present invention is used in combination or in combination with bactericides, insecticides / acaricides, nematicides, soil insecticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds, etc. May be.
  • the compound of the present invention is useful as an active ingredient of an ectoparasite control agent because it is excellent in the control effect of ectoparasites harmful to humans.
  • ectoparasites include ticks, lice and fleas.
  • host animals to be treated with the ectoparasite control agent of the present invention include pets such as dogs and cats; pets; domestic animals such as cattle, horses, pigs, and sheep; It is done.
  • a bee is mentioned.
  • Ectoparasites parasitize in and on host animals, particularly warm-blooded animals. Specifically, it infests the back, underarms, lower abdomen, and inner crotch of the host animal and obtains nutrients such as blood and dandruff from the animal.
  • the ectoparasite control agent of the present invention can be applied by a known veterinary technique (topical, oral, parenteral or subcutaneous administration).
  • a known veterinary technique topical, oral, parenteral or subcutaneous administration
  • it is administered orally to animals by tablet, capsule, feed mixing, etc .; it is administered to animals by immersion liquid, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.); A method of locally administering an aqueous solution by spraying, pour-on, spot-on, etc .; kneading an ectoparasite-controlling agent into a resin, shaping the kneaded product into an appropriate shape such as a collar or ear tag, and applying it to an animal A method of wearing and administering locally;
  • Formulation 1 wettable powder
  • Compound of the present invention 40 parts Diatomaceous earth 53 parts Higher alcohol sulfate 4 parts Alkyl naphthalene sulfonate 3 parts The above components were mixed uniformly and finely pulverized to obtain a wettable powder of 40% active ingredient.
  • Formulation 3 Granules
  • Compound of the present invention 5 parts Talc 40 parts Clay 38 parts Bentonite 10 parts Sodium alkyl sulfate 7 parts or more are uniformly mixed and finely pulverized, then granulated into granules having a diameter of 0.5 to 1.0 mm and active ingredient 5% Get the granules.
  • Formulation 4 Granules
  • Compound of the present invention 5 parts Clay 73 parts Bentonite 20 parts Dioctylsulfosuccinate sodium salt 1 part Potassium phosphate 1 part or more is pulverized and mixed well, water is added and kneaded well, granulated and dried, and 5% active ingredient Get the granules.
  • Formulation 6 Granules
  • Compound of the present invention 5 parts Kaolin 94 parts White carbon 1 part
  • the compound of the present invention is dissolved in an organic solvent, sprayed onto a carrier, and then the solvent is evaporated under reduced pressure. This type of granule can be mixed with animal food.
  • Formulation 7 Injection
  • Compound of the present invention 0.1-1 part Peanut oil After balance preparation, filter sterilize with a sterilization filter.
  • 6- (3,3-dimethylbutoxy) -N′-ethoxypyrimidine-4-carboxyimidamide was mixed with 3 ml of acetic acid and 6 ml of concentrated hydrochloric acid.
  • An aqueous solution of 0.23 g (3.36 mmol) of sodium nitrite was added dropwise to the mixture at ⁇ 15 ° C. Then, it stirred at room temperature for 4 hours.
  • Ethyl acetate was added thereto and neutralized with an aqueous sodium hydroxide solution. Then, it extracted with ethyl acetate.
  • Example 2 6- (3,3-Dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-isopropyloxime (compound number 1-2) Manufactured.
  • Example 3 6- (3,3-Dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-methyloxime (Compound No. 1-3) Manufactured.
  • 1 H-NMR data of the obtained 6- (3,3-dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-methyloxime (CDCl 3 / TMS ⁇ (ppm)): 8.82-8.81 (2H, m), 8.09 (1H, s), 7.03 (1H, d), 4.51-4.45 (2H, m), 4.16 (3H, s), 1.74-1.70 (2H , m), 0.99 (9H, s).
  • Example 5 (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-- Isopropyl oxime (Compound No. 1-77) was prepared.
  • Example 6 (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-- Methyl oxime (Compound No. 1-75) was prepared.
  • Table 3 shows the physical property values of the compounds described in Tables 1 and 2 above. “Mp” represents the melting point. “ND” represents a refractive index.
  • Test Example 1 Efficacy Test for Bean Aphids First, 5 parts of the compound of the present invention, 93.6 parts of dimethylformamide and 1.4 parts of polyoxyethylene alkylaryl ether were mixed and dissolved to prepare an emulsion containing 5% active ingredient. did. The bean aphid was released on the cowpea where the primary leaves developed. When 1 day had passed since the release, the 1st instar larvae were left and adults were removed. Subsequently, the emulsion was diluted with water to a compound concentration of 125 ppm, and this chemical solution was sprayed on the cowpea. Thereafter, the cowpea was kept in a temperature-controlled room at a temperature of 25 ° C. and a humidity of 60%.
  • Test Example 2 Efficacy test against brown planthopper
  • the emulsion described in Test Example 1 was diluted with water to a compound concentration of 125 ppm, rice seedlings were immersed in this chemical solution for 10 seconds, and then air-dried. A plastic bag with holes was put on rice seedlings. Ten second instar larvae were released in plastic bags.
  • the rice seedlings were kept in a thermostatic chamber at a temperature of 25 ° C. and a humidity of 60%. When 6 days had passed since the release of the insects, the survival of the brown planthopper was examined and the insecticidal rate was determined.
  • two types of (A) drug-sensitive lines and (B) drug-insensitive lines were used as the brown planthopper.
  • the efficacy test was conducted at a compound concentration of 8 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more. 1-1, 1-2, 1-5, 1-7, 1-8, 1-10, 1-13, 1-15, 1-18, 1-20, 1-22, 1-25, 1- 32, 1-33, 1-39, 1-46, 1-47, 1-51, 1-66, 1-68, 1-69, 1-71, 1-72, 1-76, 1-78, 1-80, 1-81, 1-83, 1-86, 1-93, 1-94, 1-111, and 1-121.
  • the efficacy test was conducted at a compound concentration of 2 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more. 1-4, 1-21, 1-26, 1-35, 1-36, 1-65, and 1-77.
  • the efficacy test was conducted at a compound concentration of 31 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more. 1-2, 1-4, 1-5, 1-15, 1-26, 1-46, 1-47, 1-69, 1-80, 1-86, and 1-94.
  • the efficacy test was conducted at a compound concentration of 8 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more. 1-1, 1-21, 1-66, 1-77, and 1-78.
  • Imidacloprid showed an insecticidal rate of 100% at 125 ppm with respect to (A) drug-sensitive line. (B) The insecticidal rate was 50% for the drug-insensitive line.
  • Buprofezin showed a 100% insecticidal rate at 125 ppm with respect to (A) drug-sensitive line. (B) The insecticidal rate was 70% for the drug-insensitive line.
  • Test Example 3 Efficacy test against cotton aphids
  • Adult cotton aphids were released on cucumbers that had been sown in 3-inch pots and 10 days after germination. When 1 day had passed since the release, the 1st instar larvae were left and adults were removed.
  • the emulsion described in Test Example 1 was diluted with water so that the compound concentration was 125 ppm, and this chemical solution was sprayed onto the cucumber. Thereafter, the cucumber was kept in a constant temperature room at a temperature of 25 ° C. and a humidity of 60%. After 5 days from spraying, the aphids were examined for life and death, and the insecticidal rate was determined. The said test was done about the chemical
  • All compounds had an insecticidal rate of 80% or more. 1-1, 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1- 13, 1-15, 1-16, 1-17, 1-18, 1-19, 1-20, 1-21, 1-22, 1-25, 1-26, 1-30, 1-31, 1-32, 1-33, 1-35, 1-36, 1-37, 1-38, 1-39, 1-40, 1-41, 1-46, 1-47, 1-48, 1- 49, 1-50, 1-51, 1-58, 1-63, 1-65, 1-66, 1-69, 1-71, 1-72, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-82, 1-83, 1-86, 1-87, 1-88, 1-90, 1-91, 1-92, 1-93, 1- 94, 1-95, 1-96, 1-97, 1-98, 1-99, 1-100, 1-101, 1-104, 1-106, 1-107, 1-110, 1-111, And 1-121.
  • the efficacy test was conducted at a compound concentration of 31 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more.
  • the efficacy test was conducted at a compound concentration of 8 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more.
  • Test Example 4 Efficacy test against peach aphid
  • the emulsion described in Test Example 1 was diluted with water so that the compound concentration was 125 ppm, and the radish was immersed in this chemical solution for 10 seconds. Thereafter, the radish was kept in a temperature-controlled room at a temperature of 25 ° C. and a humidity of 60%.
  • the mortality of the peach aphid was examined to determine the insecticidal rate. The said test was done about the chemical
  • All compounds had an insecticidal rate of 80% or more.
  • the efficacy test was conducted at a compound concentration of 31 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more. 1-3, 1-10, 1-15, 1-20, 1-21, 1-26, 1-31, 1-46, 1-47, 1-48, 1-58, 1-65, 1- 66, 1-69, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-94, 1-96, 1-97, 1-98, 1-99, 1-104, 1-111, and 1-121.
  • Test Example 5 Efficacy test against leafhopper leaf
  • the emulsion described in Test Example 1 was diluted with water to a compound concentration of 125 ppm, and rice seedlings were immersed in this chemical solution for 10 seconds and allowed to air dry. A plastic bag with a hole was put on the rice seedlings. Ten second instar larvae were released in a plastic bag. Rice seedlings were kept in a constant temperature room at a temperature of 25 ° C. and a humidity of 60%. When 6 days had passed since the release, the viability of the leafhopper was examined and the insecticidal rate was determined. The said test was done about the chemical
  • the efficacy test was conducted at a compound concentration of 31 ppm.
  • the compounds shown below showed an insecticidal rate of 80% or more.
  • Test Example 6 Efficacy test against tobacco whitefly
  • the emulsion described in Test Example 1 was diluted with water so that the concentration of the compound of the present invention was 125 ppm, and this test chemical solution was sprayed on tomato cut leaves and then air-dried.
  • the leaf was fixed using absorbent cotton so that the leaf surface faced upward.
  • 7 pairs of adult whitefly whitefly type B were released, infested with tomato cut leaves, and kept in a thermostatic chamber at a temperature of 25 ° C. and a humidity of 60%. When two days had passed since the release, adults were examined for viability and the insecticidal rate was determined.
  • the said test was done about the chemical
  • All compounds had an insecticidal rate of 80% or more. 1-5, 1-10, 1-11, 1-15, 1-20, 1-21, 1-22, 1-26, 1-31, 1-32, 1-33, 1-35, 1- 36, 1-37, 1-38, 1-39, 1-40, 1-46, 1-51, 1-65, 1-66, 1-68, 1-69, 1-71, 1-72, 1-74, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-83, 1-88, 1-94, and 1-100.
  • Test Example 8 The emulsion described in Test Example 7 for wheat powdery mildew control was diluted with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration would be 100 ppm.
  • Test Example 7 The emulsion described in Test Example 7 for wheat powdery mildew control was diluted with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration would be 100 ppm.
  • the said test was done about the chemical
  • Test Example 9 Wheat red rust control test The emulsion described in Test Example 7 was diluted with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration was 100 ppm. Prepared. Subsequently, the chemical solution was sprayed on wheat seedlings grown in an unglazed pot (variety “Noribayashi No. 61”, 1.0 to 1.2 leaf stage). After air-drying the leaves, summer spores of wheat red rust fungus (Puccinia recondita) were shaken off and inoculated, and wheat seedlings were kept in a 22-25 ° C. greenhouse for 10 days. The lesion appearance state on the leaf was compared with no treatment, and the control effect was obtained. The said test was done about the chemical
  • Tomato plague control test The drug solution was prepared by diluting the emulsion described in Test Example 7 with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration was 100 ppm. did. Subsequently, the chemical solution was sprayed on tomato seedlings (variety “Regina”, 4-5 leaf stage) grown in an unglazed pot. The leaves were air-dried and then sprayed with a zoospore suspension of Phytophthora infestans, and kept in a temperature-controlled room at 20 ° C. and high humidity for 4 days, repeating light and dark every 12 hours. The lesion appearance state on the leaf was compared with no treatment, and the control effect was obtained. The above test was conducted on a chemical solution containing the compound No. 1-6. This compound exhibited a control value of 75% or more.
  • an azolyl oxime compound or a salt thereof which is excellent in insecticidal activity and / or acaricidal activity, excellent in safety and can be synthesized industrially advantageously, and a pest control agent containing this as an active ingredient.

Abstract

An azolyl oxime compound expressed by formula (I) or a salt thereof. In formula (I), Het represents a six member heteroaryl ring containing 2 to 3 nitrogen atoms as ring structural atoms. X1 is a substitution group on the Het, and represents a C1-6 alkyl group which may be unsubstituted or may have a substitution group, or a C1-6 alkoxy group which may be unsubstituted or may have a substitution group, or the like. m indicates the number of X1 groups, and is an integer from 0 to 3. A represents a carbon atom or a nitrogen atom. X2 represents a halogen group or a C1-6 alkyl group which may be unsubstituted or may have a substitution group, or the like. n indicates the number of X2 groups, and is an integer from 0 to 3. R1 represents a C1-6 alkyl group which may be unsubstituted or may have a substitution group, or the like.

Description

アゾリルオキシム化合物またはその塩、有害生物防除剤、殺虫剤または殺ダニ剤、殺菌剤、および外部寄生虫防除剤Azolyl oxime compounds or salts thereof, pest control agents, insecticides or acaricides, fungicides, and ectoparasite control agents
 本発明は、アゾリルオキシム化合物、有害生物防除剤、殺虫剤または殺ダニ剤、殺菌剤、および外部寄生虫防除剤に関する。より詳細に、本発明は、優れた殺虫活性および/または殺ダニ活性を有し、安全性に優れ、且つ工業的に有利に合成できるアゾリルオキシム化合物またはその塩、ならびにこれを有効成分として含有する有害生物防除剤、殺虫剤または殺ダニ剤、殺菌剤、および外部寄生虫防除剤に関する。
 本願は、2013年1月28日に、日本に出願された特願2013-012989号に基づき優先権を主張し、その内容をここに援用する。
The present invention relates to azolyl oxime compounds, pest control agents, insecticides or acaricides, fungicides, and ectoparasite control agents. More specifically, the present invention relates to an azolyloxime compound or a salt thereof, which has excellent insecticidal activity and / or acaricidal activity, is excellent in safety, and can be advantageously synthesized industrially, and harmful substances containing this as an active ingredient. The present invention relates to biocontrol agents, insecticides or acaricides, fungicides, and ectoparasite control agents.
This application claims priority based on Japanese Patent Application No. 2013-012989 filed in Japan on January 28, 2013, the contents of which are incorporated herein by reference.
 アゾリルオキシム化合物として、例えば、特許文献1には分子構造中にナフチルまたはピリジルとトリアゾリルまたはイミダゾリルとを有するアゾリルオキシム化合物が開示されている。前記化合物のうちいくつかはトビイロウンカ、シマグロコバエ、およびコナガに対して殺虫効果があったと特許文献1は述べている。しかし、それ以外の化合物については殺虫剤としての可能性を単に述べるのみである。また、特許文献2にはピリジン誘導体が開示されている。前記ピリジン誘導体の一つとしてアゾリルオキシム化合物が開示されている。前記化合物のうちいくつかは、モモアカアブラムシ、トビイロウンカ、シルバーリーフコナジラミなどに対して殺虫効果があったと特許文献2は述べている。しかし、それ以外の化合物については殺虫剤としての可能性を単に述べるのみである。「アゾリル」は、環員原子として、窒素原子、硫黄原子および酸素原子からなる群から選択される異種原子を二以上有する5員の飽和若しくは不飽和ヘテロシクリル基であって、異種原子のうち少なくとも一つが窒素原子である。具体的にはトリアゾリル、イミダゾリルなどが挙げられる。 As an azolyl oxime compound, for example, Patent Document 1 discloses an azolyl oxime compound having naphthyl or pyridyl and triazolyl or imidazolyl in the molecular structure. Patent Document 1 states that some of the compounds had an insecticidal effect against leafhopper, leafhopper, and diamondback moth. However, other compounds are merely described as potential insecticides. Patent Document 2 discloses a pyridine derivative. An azolyl oxime compound is disclosed as one of the pyridine derivatives. Patent Document 2 states that some of the compounds had an insecticidal effect against peach aphid, brown planthopper, silver leaf whitefly, and the like. However, other compounds are merely described as potential insecticides. “Azolyl” is a 5-membered saturated or unsaturated heterocyclyl group having two or more hetero atoms selected from the group consisting of a nitrogen atom, a sulfur atom and an oxygen atom as ring member atoms, and at least one of the hetero atoms. One is a nitrogen atom. Specific examples include triazolyl and imidazolyl.
特開平03-68559号公報Japanese Patent Laid-Open No. 03-68559 特開2010-138166号公報JP 2010-138166 A
 本発明の課題は、有害生物防除活性、その中でも特に殺虫活性および/または殺ダニ活性に優れ、安全性に優れ、且つ工業的に有利に合成できるアゾリルオキシム化合物またはその塩を提供すること、ならびにこれを有効成分として含有する有害生物防除剤、および、殺虫剤または殺ダニ剤を提供することである。さらに、これを有効成分として含有する殺菌剤、および外部寄生虫防除剤を提供することである。 An object of the present invention is to provide an azolyl oxime compound or a salt thereof, which is excellent in pest control activity, in particular, insecticidal activity and / or acaricidal activity, is excellent in safety, and can be synthesized advantageously industrially, and It is to provide a pest control agent containing an active ingredient as an active ingredient, and an insecticide or acaricide. Furthermore, it is providing the bactericidal agent containing this as an active ingredient, and an ectoparasite control agent.
 本発明者らは、上記課題を解決すべく鋭意検討した結果、ジアジン環やトリアジン環などの特定の構造を有するアゾリルオキシム化合物またはその塩は、優れた殺虫活性および/または殺ダニ活性を有し、且つ良好な特性と高い安全性を示し、有害生物防除剤の有効成分として利用できることを見出した。さらに、殺菌剤、および外部寄生虫防除剤の有効成分として利用できることを見出した。本発明は、この知見に基づいて完成するに至った。 As a result of intensive studies to solve the above problems, the present inventors have found that an azolyloxime compound having a specific structure such as a diazine ring or a triazine ring or a salt thereof has excellent insecticidal activity and / or acaricidal activity, It was also found that it has good characteristics and high safety and can be used as an active ingredient of a pest control agent. Furthermore, it discovered that it could utilize as an active ingredient of a disinfectant and an ectoparasite control agent. The present invention has been completed based on this finding.
 すなわち、本発明は、以下のものを含む。
〔1〕 式(I)で表されるアゾリルオキシム化合物またはその塩。
That is, the present invention includes the following.
[1] An azolyl oxime compound represented by the formula (I) or a salt thereof.
Figure JPOXMLDOC01-appb-C000004
Figure JPOXMLDOC01-appb-C000004
 式(I)中、Hetは、2~3個の窒素原子を環の構成原子として含む6員ヘテロアリール環を示す。
 X1は、Het上の置換基であって、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC2~6アルケニルオキシ基、無置換のもしくは置換基を有するC2~6アルキニルオキシ基、無置換のもしくは置換基を有するC3~8シクロアルキルオキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するC1~6アルキルカルバモイル基、無置換のもしくは置換基を有するアミノ基、メルカプト基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルフィニル基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、無置換のもしくは置換基を有するC6~10アリールオキシ基、ハロゲノ基、シアノ基、またはニトロ基を示す。
 mは、X1の個数を示しかつ0~3のいずれかの整数である。mが2以上のときX1は互いに同一でも異なっていてもよい。
 Aは、炭素原子または窒素原子を示す。
 X2は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するアミノ基、メルカプト基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、ハロゲノ基、シアノ基、またはニトロ基を示す。
 nは、X2の個数を示しかつ0~3のいずれかの整数である。nが2以上のときX2は互いに同一でも異なっていてもよい。
 R1は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、無置換のもしくは置換基を有するC6~10アリール基、または無置換のもしくは置換基を有する3~6員ヘテロシクリル基を示す。
 式(I)中、交差した実線で表した結合は、立体異性を有する二重結合を示す。
In the formula (I), Het represents a 6-membered heteroaryl ring containing 2 to 3 nitrogen atoms as constituent atoms of the ring.
X 1 is a substituent on Het, which is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted C2-6 alkenyloxy Group, unsubstituted or substituted C2-6 alkynyloxy group, unsubstituted or substituted C3-8 cycloalkyloxy group, unsubstituted or substituted C1-7 acyl group, unsubstituted Or a substituted C1-6 alkoxycarbonyl group, an unsubstituted or substituted C1-6 alkylcarbamoyl group, unsubstituted Or a substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1 ~ 6 alkylsulfonyl group, unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl group, unsubstituted or substituted C6-10 aryloxy group, halogeno A group, a cyano group, or a nitro group;
m represents the number of X 1 and is an integer from 0 to 3. When m is 2 or more, X 1 may be the same as or different from each other.
A represents a carbon atom or a nitrogen atom.
X 2 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group A C1-6 alkoxycarbonyl group, an unsubstituted or substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfonyl group, Unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl Shows a halogeno group, a cyano group or a nitro group.
n represents the number of X 2 and is an integer from 0 to 3. When n is 2 or more, X 2 may be the same as or different from each other.
R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted 3-6 membered heterocyclyl group is shown.
In the formula (I), a bond represented by crossed solid lines represents a double bond having stereoisomerism.
〔2〕 mが、1、2、又は3のいずれかの整数である前記〔1〕に記載のアゾリルオキシム化合物またはその塩。
〔3〕 前記式(I)が、式(II)で表される、前記〔1〕に記載のアゾリルオキシム化合物またはその塩。
[2] The azolyl oxime compound or a salt thereof according to [1], wherein m is an integer of any one of 1, 2, or 3.
[3] The azolyloxime compound or a salt thereof according to [1], wherein the formula (I) is represented by the formula (II).
Figure JPOXMLDOC01-appb-C000005
Figure JPOXMLDOC01-appb-C000005
 式(II)中、X11は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するアミノ基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルフィニル基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、ハロゲノ基、シアノ基、またはニトロ基を示す。
 m1は、X11の個数を示しかつ0~2のいずれかの整数である。m1が2以上のときX11は互いに同一でも異なっていてもよい。
 X1、A、X2、n、R1、および交差した実線で表した結合は、前記のとおりである。
〔4〕 式(III)で表されるアゾリルオキシム化合物またはその塩。
In the formula (II), X 11 represents an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl Group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted amino group, unsubstituted or substituted A C1-6 alkylthio group having a group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1-6 alkylsulfonyl group, a halogeno group, a cyano group, or a nitro group .
m1 represents the number of X 11 and is an integer from 0 to 2. When m1 is 2 or more, X 11 may be the same as or different from each other.
The bonds represented by X 1 , A, X 2 , n, R 1 and the crossed solid line are as described above.
[4] An azolyl oxime compound represented by the formula (III) or a salt thereof.
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
 式(III)中、X1、X11、m1、A、X2、n、R1、および交差した実線で表した結合は、前記のとおりである。 In formula (III), X 1 , X 11 , m 1, A, X 2 , n, R 1 , and the bond represented by the crossed solid line are as described above.
〔5〕 前記〔1〕~〔4〕のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する有害生物防除剤。
〔6〕 前記〔1〕~〔4〕のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺虫剤または殺ダニ剤。
〔7〕 前記〔1〕~〔4〕のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺菌剤。
〔8〕 前記〔1〕~〔4〕のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する外部寄生虫防除剤。
[5] A pest control agent comprising as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] and a salt thereof.
[6] An insecticide or acaricide containing as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] and a salt thereof.
[7] A bactericide containing as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] and a salt thereof.
[8] An ectoparasite control agent comprising as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of [1] to [4] above and a salt thereof.
 本発明のアゾリルオキシム化合物またはその塩は、農作物や衛生面で問題となる有害生物を防除することができる。特に農業害虫およびダニ類を効果的に防除することができる。さらには、植物病害を効果的に防除することができる。さらに、人畜を害する外部寄生虫を効果的に防除することができる。 The azolyloxime compound or a salt thereof of the present invention can control pests that are problematic in terms of crops and hygiene. In particular, agricultural pests and mites can be effectively controlled. Furthermore, plant diseases can be effectively controlled. Furthermore, ectoparasites that harm human livestock can be effectively controlled.
 以下、本発明の好ましい例を説明するが、本発明はこれら例に限定されることはない。本発明の趣旨を逸脱しない範囲で、構成の付加、省略、置換、およびその他の変更が可能である。
 本発明のアゾリルオキシム化合物は、式(I)で表される化合物(以下、化合物(I)と表記することがある。)である。
Hereinafter, preferred examples of the present invention will be described, but the present invention is not limited to these examples. Additions, omissions, substitutions, and other modifications can be made without departing from the spirit of the present invention.
The azolyloxime compound of the present invention is a compound represented by the formula (I) (hereinafter sometimes referred to as compound (I)).
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
 まず、本発明において、「無置換の」の用語は、母核となる基のみであることを意味する。「置換基を有する」との記載がなく母核となる基の名称のみで記載しているときは、別段の断りがない限り「無置換の」の意味である。
 一方、「置換基を有する」の用語は、母核となる基のいずれかの水素原子が、母核と同一または異なる構造の基で置換されていることを意味する。従って、「置換基」は、母核となる基に結合した他の基である。置換基は1つであってもよいし、2つ以上であってもよい。2つ以上の置換基は同一であってもよいし、異なるものであってもよい。
 「C1~6」などの用語は、母核となる基の炭素原子数が1~6個などであることを表している。この炭素原子数には、置換基の中に在る炭素原子の数を含まない。例えば、置換基としてエトキシ基を有するブチル基は、C2アルコキシC4アルキル基に分類する。
First, in the present invention, the term “unsubstituted” means only a group serving as a mother nucleus. When there is no description of “having a substituent” and only the name of the group serving as a mother nucleus is used, it means “unsubstituted” unless otherwise specified.
On the other hand, the term “having a substituent” means that any hydrogen atom of a group serving as a mother nucleus is substituted with a group having the same or different structure from the mother nucleus. Accordingly, the “substituent” is another group bonded to a group serving as a mother nucleus. The number of substituents may be one, or two or more. Two or more substituents may be the same or different.
Terms such as “C1-6” indicate that the group serving as the mother nucleus has 1 to 6 carbon atoms. This number of carbon atoms does not include the number of carbon atoms present in the substituent. For example, a butyl group having an ethoxy group as a substituent is classified as a C2 alkoxy C4 alkyl group.
 「置換基」は化学的に許容され、本発明の効果を有する限りにおいて特に制限されない。以下に「置換基」となり得る基を例示する。
 メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、s-ブチル基、i-ブチル基、t-ブチル基、n-ペンチル基、n-ヘキシル基などのC1~6アルキル基;
 ビニル基、1-プロペニル基、2-プロペニル基(別名:アリル基)、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基などのC2~6アルケニル基;
 エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基などのC2~6アルキニル基;
 シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロへプチル基、シクロオクチル基などのC3~8シクロアルキル基;
 2-シクロペンテニル基、3-シクロヘキセニル基、4-シクロオクテニル基などのC4~8シクロアルケニル基;
The “substituent” is not particularly limited as long as it is chemically acceptable and has the effects of the present invention. Examples of groups that can be “substituents” are shown below.
C1-6 such as methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n-hexyl group, etc. An alkyl group;
Vinyl group, 1-propenyl group, 2-propenyl group (also known as allyl group), 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group A C2-6 alkenyl group such as a group;
C2-6 alkynyl groups such as ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group;
A C3-8 cycloalkyl group such as a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group;
A C4-8 cycloalkenyl group such as a 2-cyclopentenyl group, a 3-cyclohexenyl group, a 4-cyclooctenyl group;
 フェニル基、ナフチル基などのC6~10アリール基;
 ベンジル基、フェネチル基などのC6~10アリールC1~6アルキル基;
 3~6員ヘテロシクリル基;
 3~6員ヘテロシクリルC1~6アルキル基;
 ホルミル基、アセチル基、プロピオニル基、ベンゾイル基、シクロヘキシルカルボニル基などのC1~7アシル基;
A C6-10 aryl group such as a phenyl group or a naphthyl group;
A C6-10 aryl C1-6 alkyl group such as a benzyl group or a phenethyl group;
3-6 membered heterocyclyl group;
A 3-6 membered heterocyclyl C1-6 alkyl group;
A C1-7 acyl group such as a formyl group, an acetyl group, a propionyl group, a benzoyl group, a cyclohexylcarbonyl group;
 ヒドロキシ基;
 メトキシ基、エトキシ基、n-プロポキシ基、i-プロポキシ基、n-ブトキシ基、s-ブトキシ基、i-ブトキシ基、t-ブトキシ基などのC1~6アルコキシ基;
 ビニルオキシ基、アリルオキシ基、プロペニルオキシ基、ブテニルオキシ基などのC2~6アルケニルオキシ基;
 エチニルオキシ基、プロパルギルオキシ基などのC2~6アルキニルオキシ基;
 フェノキシ基、1-ナフトキシ基などのC6~10アリールオキシ基;
 ベンジルオキシ基、フェネチルオキシ基などのC6~10アリールC1~6アルコキシ基;
3~6員ヘテロシクリルオキシ基;
3~6員ヘテロシクリルC1~6アルコキシ基;
A hydroxy group;
C1-6 alkoxy groups such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, t-butoxy group;
C2-6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group, butenyloxy group;
C2-6 alkynyloxy groups such as ethynyloxy group and propargyloxy group;
C6-10 aryloxy groups such as phenoxy group and 1-naphthoxy group;
A C6-10 aryl C1-6 alkoxy group such as a benzyloxy group or a phenethyloxy group;
A 3-6 membered heterocyclyloxy group;
A 3-6 membered heterocyclyl C1-6 alkoxy group;
 ホルミルオキシ基、アセチルオキシ基、プロピオニルオキシ基、ベンゾイルオキシ基、シクロヘキシルカルボニルオキシ基などのC1~7アシルオキシ基;
 メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基、n-ブトキシカルボニル基、t-ブトキシカルボニル基などのC1~6アルコキシカルボニル基;
 カルボキシル基;
C1-7 acyloxy groups such as formyloxy group, acetyloxy group, propionyloxy group, benzoyloxy group, cyclohexylcarbonyloxy group;
A C1-6 alkoxycarbonyl group such as a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, a t-butoxycarbonyl group;
Carboxyl group;
 フルオロ基、クロロ基、ブロモ基、イオド基などのハロゲノ基;
 クロロメチル基、クロロエチル基、トリフルオロメチル基、1,2-ジクロロ-n-プロピル基、1-フルオロ-n-ブチル基、パーフルオロ-n-ペンチル基などのC1~6ハロアルキル基;
 2-クロロ-1-プロペニル基、2-フルオロ-1-ブテニル基などのC2~6ハロアルケニル基;
 4,4-ジクロロ-1-ブチニル基、4-フルオロ-1-ペンチニル基、5-ブロモ-2-ペンチニル基などのC2~6ハロアルキニル基;
 4-クロロフェニル基、4-フルオロフェニル基、2,4-ジクロロフェニル基などのC6~10ハロアリール基;
 トリフルオロメトキシ基、2-クロロ-n-プロポキシ基、2,3-ジクロロブトキシ基などのC1~6ハロアルコキシ基;
 2-クロロプロペニルオキシ基、3-ブロモブテニルオキシ基などのC2~6ハロアルケニルオキシ基;
 4-フルオロフェニルオキシ基、4-クロロ-1-ナフトキシ基などのC6~10ハロアリールオキシ基;
 クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基、4-クロロベンゾイル基などのC1~7ハロアシル基;
Halogeno groups such as fluoro, chloro, bromo and iodo groups;
C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, perfluoro-n-pentyl group;
A C2-6 haloalkenyl group such as a 2-chloro-1-propenyl group and a 2-fluoro-1-butenyl group;
A C2-6 haloalkynyl group such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, 5-bromo-2-pentynyl group;
C6-10 haloaryl group such as 4-chlorophenyl group, 4-fluorophenyl group, 2,4-dichlorophenyl group;
A C1-6 haloalkoxy group such as a trifluoromethoxy group, 2-chloro-n-propoxy group, 2,3-dichlorobutoxy group;
A C2-6 haloalkenyloxy group such as a 2-chloropropenyloxy group and a 3-bromobutenyloxy group;
C6-10 haloaryloxy groups such as 4-fluorophenyloxy group, 4-chloro-1-naphthoxy group;
C1-7 haloacyl groups such as chloroacetyl group, trifluoroacetyl group, trichloroacetyl group, 4-chlorobenzoyl group;
 アミノ基;
 メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基などのC1~6アルキルアミノ基;
 アニリノ基、ナフチルアミノ基などのC6~10アリールアミノ基;
 ベンジルアミノ基、フェネチルアミノ基などのC6~10アリールC1~6アルキルアミノ基;
 ホルミルアミノ基、アセチルアミノ基、プロパノイルアミノ基、ブチリルアミノ基、i-プロピルカルボニルアミノ基、ベンゾイルアミノ基などのC1~7アシルアミノ基;
 メトキシカルボニルアミノ基、エトキシカルボニルアミノ基、n-プロポキシカルボニルアミノ基、i-プロポキシカルボニルアミノ基などのC1~6アルコキシカルボニルアミノ基;
 アミノカルボニル基、ジメチルアミノカルボニル基、フェニルアミノカルボニル基、N-フェニル-N-メチルアミノカルボニル基などの無置換若しくは置換基を有するアミノカルボニル基;
 イミノメチル基、(1-イミノ)エチル基、(1-イミノ)-n-プロピル基などのイミノ基で置換されたC1~6アルキル基;
 N-ヒドロキシ-イミノメチル基、(1-(N-ヒドロキシ)-イミノ)エチル基、(1-(N-ヒドロキシ)-イミノ)プロピル基、N-メトキシ-イミノメチル基、(1-(N-メトキシ)-イミノ)エチル基などの無置換の若しくは置換基を有するN-ヒドロキシイミノC1~6アルキル基;
An amino group;
A C1-6 alkylamino group such as a methylamino group, a dimethylamino group, a diethylamino group;
C6-10 arylamino groups such as anilino group and naphthylamino group;
A C6-10 aryl C1-6 alkylamino group such as a benzylamino group or a phenethylamino group;
C1-7 acylamino groups such as formylamino group, acetylamino group, propanoylamino group, butyrylamino group, i-propylcarbonylamino group, benzoylamino group;
A C1-6 alkoxycarbonylamino group such as a methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group;
An aminocarbonyl group having no substituent or a substituent such as an aminocarbonyl group, a dimethylaminocarbonyl group, a phenylaminocarbonyl group, an N-phenyl-N-methylaminocarbonyl group;
A C1-6 alkyl group substituted with an imino group such as an iminomethyl group, a (1-imino) ethyl group, a (1-imino) -n-propyl group;
N-hydroxy-iminomethyl group, (1- (N-hydroxy) -imino) ethyl group, (1- (N-hydroxy) -imino) propyl group, N-methoxy-iminomethyl group, (1- (N-methoxy) -Imino) N-hydroxyimino C1-6 alkyl group which is unsubstituted or has a substituent such as ethyl group;
 メルカプト基;
 メチルチオ基、エチルチオ基、n-プロピルチオ基、i-プロピルチオ基、n-ブチルチオ基、i-ブチルチオ基、s-ブチルチオ基、t-ブチルチオ基などのC1~6アルキルチオ基;
 フェニルチオ基、ナフチルチオ基などのC6~10アリールチオ基;
 ベンジルチオ基、フェネチルチオ基などのC6~10アリールC1~6アルキルチオ基;
 メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基などのC1~6アルキルスルフィニル基;
 フェニルスルフィニル基などのC6~10アリールスルフィニル基;
 ベンジルスルフィニル基、フェネチルスルフィニル基などのC6~10アリールC1~6アルキルスルフィニル基;
メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基などのC1~6アルキルスルホニル基;
 フェニルスルホニル基などのC6~10アリールスルホニル基;
 ベンジルスルホニル基、フェネチルスルホニル基などのC6~10アリールC1~6アルキルスルホニル基;
アミノカルボニルオキシ基;
 エチルアミノカルボニルオキシ基、ジメチルアミノカルボニルオキシ基などのC1~6アルキル置換アミノカルボニルオキシ基;
A mercapto group;
C1-6 alkylthio groups such as methylthio group, ethylthio group, n-propylthio group, i-propylthio group, n-butylthio group, i-butylthio group, s-butylthio group, t-butylthio group;
A C6-10 arylthio group such as a phenylthio group or a naphthylthio group;
A C6-10 aryl C1-6 alkylthio group such as a benzylthio group or a phenethylthio group;
A C1-6 alkylsulfinyl group such as a methylsulfinyl group, an ethylsulfinyl group, a t-butylsulfinyl group;
A C6-10 arylsulfinyl group such as a phenylsulfinyl group;
A C6-10 aryl C1-6 alkylsulfinyl group such as a benzylsulfinyl group, a phenethylsulfinyl group;
A C1-6 alkylsulfonyl group such as a methylsulfonyl group, an ethylsulfonyl group, a t-butylsulfonyl group;
A C6-10 arylsulfonyl group such as a phenylsulfonyl group;
A C6-10 aryl C1-6 alkylsulfonyl group such as a benzylsulfonyl group or a phenethylsulfonyl group;
An aminocarbonyloxy group;
A C1-6 alkyl-substituted aminocarbonyloxy group such as an ethylaminocarbonyloxy group or a dimethylaminocarbonyloxy group;
 トリメチルシリル基、トリエチルシリル基、t-ブチルジメチルシリル基などのトリC1~6アルキル置換シリル基;
 トリフェニルシリル基;
 シアノ基;ニトロ基;
 また、これらの「置換基」は、前記置換基中のいずれかの水素原子が、異なる構造の基で置換されていてもよい。
A tri-C1-6 alkyl-substituted silyl group such as a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group;
A triphenylsilyl group;
Cyano group; nitro group;
In these “substituents”, any hydrogen atom in the substituent may be substituted with a group having a different structure.
 また、上記の「3~6員ヘテロシクリル基」とは、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1~4個のヘテロ原子を環の構成原子として含む。ヘテロシクリル基は、単環および多環のいずれであってもよい。多環ヘテロシクリル基は、少なくとも一つの環がヘテロシクリルであれば、残りの環が飽和脂環、不飽和脂環または芳香環のいずれであってもよい。「3~6員ヘテロシクリル基」としては、3~6員飽和へテロシクリル基、5~6員ヘテロアリール基、5~6員部分不飽和へテロシクリル基などを挙げることができる。 In addition, the “3- to 6-membered heterocyclyl group” includes 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as ring constituent atoms. The heterocyclyl group may be monocyclic or polycyclic. In the polycyclic heterocyclyl group, when at least one ring is heterocyclyl, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the “3- to 6-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, and a 5- to 6-membered partially unsaturated heterocyclyl group.
 3~6員飽和ヘテロシクリル基としては、アジリジニル基、オキシラニル基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などが挙げられる。 Examples of the 3- to 6-membered saturated heterocyclyl group include aziridinyl group, oxiranyl group, azetidinyl group, oxetanyl group, pyrrolidinyl group, tetrahydrofuranyl group, thiazolidinyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, and dioxanyl group. .
 5員ヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などが挙げられる。
 6員ヘテロアリール基としては、ピリジル基、ピラジニル基、ピリミジニル基、ピリダニジル基、トリアジニル基などが挙げられる。
Examples of the 5-membered heteroaryl group include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, etc. .
Examples of the 6-membered heteroaryl group include a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridanidyl group, and a triazinyl group.
〔Het〕
 Hetは、2~3個の窒素原子を環の構成原子として含む6員ヘテロアリール環を示す。Hetはピリミジン環であることが好ましい。
[Het]
Het represents a 6-membered heteroaryl ring containing 2 to 3 nitrogen atoms as constituent atoms of the ring. Het is preferably a pyrimidine ring.
〔X1、m〕
 X1は、Het上の置換基であって、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC2~6アルケニルオキシ基、無置換のもしくは置換基を有するC2~6アルキニルオキシ基、無置換のもしくは置換基を有するC3~8シクロアルキルオキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するC1~6アルキルカルバモイル基、無置換のもしくは置換基を有するアミノ基、メルカプト基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルフィニル基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、無置換のもしくは置換基を有するC6~10アリールオキシ基、ハロゲノ基、シアノ基、またはニトロ基を示す。
 mは、X1の個数を示しかつ0~3のいずれかの整数である。mが2以上のときX1は互いに同一でも異なっていてもよい。
 本発明においては、mは1、2、又は3のいずれかの整数であることが好ましい。
[X 1, m]
X 1 is a substituent on Het, which is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted C2-6 alkenyloxy Group, unsubstituted or substituted C2-6 alkynyloxy group, unsubstituted or substituted C3-8 cycloalkyloxy group, unsubstituted or substituted C1-7 acyl group, unsubstituted Or a substituted C1-6 alkoxycarbonyl group, an unsubstituted or substituted C1-6 alkylcarbamoyl group, unsubstituted Or a substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1 ~ 6 alkylsulfonyl group, unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl group, unsubstituted or substituted C6-10 aryloxy group, halogeno A group, a cyano group, or a nitro group;
m represents the number of X 1 and is an integer from 0 to 3. When m is 2 or more, X 1 may be the same as or different from each other.
In the present invention, m is preferably an integer of 1, 2, or 3.
 X1における「C1~6アルキル基」は、直鎖であってもよいし、分岐鎖であってもよい。アルキル基としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ペンチル基、n-ヘキシル基、i-プロピル基、i-ブチル基、s-ブチル基、t-ブチル基、i-ペンチル基、ネオペンチル基、2-メチルブチル基、2,2-ジメチルプロピル基、i-ヘキシル基、3,3-ジメチルブチル基などが挙げられる。 The “C1-6 alkyl group” for X 1 may be linear or branched. Examples of the alkyl group include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, i-propyl group, i-butyl group, s-butyl group and t-butyl group. I-pentyl group, neopentyl group, 2-methylbutyl group, 2,2-dimethylpropyl group, i-hexyl group, 3,3-dimethylbutyl group and the like.
「置換基を有するC1~6アルコキシ基」において、置換基としては、ハロゲノ基、C3~8シクロアルキル基、ヒドロキシ基、C1~6アルコキシ基、C6~10アリール基、C1~7アシル基、C1~6アルコキシカルボニル基などが挙げられる。 In the “C1-6 alkoxy group having a substituent”, examples of the substituent include a halogeno group, a C3-8 cycloalkyl group, a hydroxy group, a C1-6 alkoxy group, a C6-10 aryl group, a C1-7 acyl group, a C1 Up to 6 alkoxycarbonyl groups.
具体的な「置換基を有するC1~6アルキル基」としては、
 フルオロメチル基、クロロメチル基、ブロモメチル基、ジフルオロメチル基、ジクロロメチル基、ジブロモメチル基、トリフルオロメチル基、トリクロロメチル基、トリブロモメチル基、2,2,2-トルフルオロエチル基、2,2,2-トリクロロエチル基、ペンタフルオロエチル基、4-フルオロブチル基、4-クロロブチル基、3,3,3-トリフルオロプロピル基、2,2,2-トリフルオロ-1-トリフルオロメチルエチル基、パーフロロヘキシル基、パークロロヘキシル基、2,4,6-トリクロロヘキシル基、パーフルオロプロピル基、パーフルオロブチル基、パーフルオロペンチル基、3,3,4,4,5,5,5-ヘプタフルオロペンチル基、2,2,3,3,4,4,5,5,5-ノナフルオロペンチル基などのC1~6ハロアルキル基;
シクロプロピルメチル基、2-シクロプロピルエチル基、シクロペンチルメチル基、2-シクロヘキシルエチル基、2-シクロオクチルエチル基などのC3~8シクロアルキルC1~6アルキル基;
Specific examples of the “C1-6 alkyl group having a substituent” include
Fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, dichloromethyl group, dibromomethyl group, trifluoromethyl group, trichloromethyl group, tribromomethyl group, 2,2,2-trifluoroethyl group, 2, 2,2-trichloroethyl group, pentafluoroethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 3,3,3-trifluoropropyl group, 2,2,2-trifluoro-1-trifluoromethylethyl Group, perfluorohexyl group, perchlorohexyl group, 2,4,6-trichlorohexyl group, perfluoropropyl group, perfluorobutyl group, perfluoropentyl group, 3,3,4,4,5,5,5 -C1 ~ such as heptafluoropentyl group, 2,2,3,3,4,4,5,5,5-nonafluoropentyl group Haloalkyl groups;
C3-8 cycloalkyl C1-6 alkyl groups such as cyclopropylmethyl group, 2-cyclopropylethyl group, cyclopentylmethyl group, 2-cyclohexylethyl group, 2-cyclooctylethyl group;
 ヒドロキシメチル基、2-ヒドロキシエチル基などのヒドロキシC1~6アルキル基;
 メトキシメチル基、エトキシメチル基、メトキシエチル基、エトキシエチル基、メトキシ-n-プロピル基、エトキシメチル基、エトキシエチル基、n-プロポキシメチル基、i-プロポキシエチル基、s-ブトキシメチル基、t-ブトキシエチル基などのC1~6アルコキシC1~6アルキル基;
 ベンジル基、フェネチル基などのC6~10アリールC1~6アルキル基;
ホルミルメチル基、アセチルメチル基、プロピオニルメチル基などのC1~7アシルC1~6アルキル基;
 メトキシカルボニルメチル基、エトキシカルボニルメチル基、n-プロポキシカルボニルメチル基、i-プロポキシカルボニルメチル基などのC1~6アルコキシカルボニルC1~6アルキル基; 
などが挙げられる。
Hydroxy C1-6 alkyl groups such as hydroxymethyl group, 2-hydroxyethyl group;
Methoxymethyl group, ethoxymethyl group, methoxyethyl group, ethoxyethyl group, methoxy-n-propyl group, ethoxymethyl group, ethoxyethyl group, n-propoxymethyl group, i-propoxyethyl group, s-butoxymethyl group, t A C1-6 alkoxy C1-6 alkyl group such as a butoxyethyl group;
A C6-10 aryl C1-6 alkyl group such as a benzyl group or a phenethyl group;
C1-7 acyl C1-6 alkyl group such as formylmethyl group, acetylmethyl group, propionylmethyl group;
A C1-6 alkoxycarbonyl C1-6 alkyl group such as a methoxycarbonylmethyl group, an ethoxycarbonylmethyl group, an n-propoxycarbonylmethyl group, an i-propoxycarbonylmethyl group;
Etc.
 X1における「C2~6アルケニル基」としては、ビニル基、1-プロペニル基、2-プロペニル基(アリル基)、1-ブテニル基、2-ブテニル基、3-ブテニル基、1-メチル-2-プロペニル基、2-メチル-2-プロペニル基、1-ペンテニル基、2-ペンテニル基、3-ペンテニル基、4-ペンテニル基、1-メチル-2-ブテニル基、2-メチル-2-ブテニル基、1-ヘキセニル基、2-ヘキセニル基、3-ヘキセニル基、4-ヘキセニル基、5-ヘキセニル基などが挙げられる。
 「置換基を有するC2~6アルケニル基」としては、2-クロロ-1-プロペニル基、2-フルオロ-1-ブテニル基などのC2~6ハロアルケニル基などが挙げられる。
Examples of the “C2-6 alkenyl group” for X 1 include a vinyl group, 1-propenyl group, 2-propenyl group (allyl group), 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2 -Propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
Examples of the “substituted C2-6 alkenyl group” include C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group.
 X1における「C2~6アルキニル基」としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基、1-メチル-2-プロピニル基、2-メチル-3-ブチニル基、1-ペンチニル基、2-ペンチニル基、3-ペンチニル基、4-ペンチニル基、1-メチル-2-ブチニル基、2-メチル-3-ペンチニル基、1-ヘキシニル基、1,1-ジメチル-2-ブチニル基などが挙げられる。
 「置換基を有するC2~6アルキニル基」としては、4,4-ジクロロ-1-ブチニル基、4-フルオロ-1-ペンチニル基、5-ブロモ-2-ペンチニル基などのC2~6ハロアルキニル基などが挙げられる。
Examples of the “C2-6 alkynyl group” in X 1 include ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl Group, 1,1-dimethyl-2-butynyl group and the like.
As the “substituted C2-6 alkynyl group”, a C2-6 haloalkynyl group such as a 4,4-dichloro-1-butynyl group, a 4-fluoro-1-pentynyl group, a 5-bromo-2-pentynyl group, etc. Etc.
 X1における「C3~8シクロアルキル基」としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基などが挙げられる。 Examples of the “C3-8 cycloalkyl group” for X 1 include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and the like.
 X1における「C1~6アルコキシ基」としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基、n-ペンチルオキシ基、n-ヘキシルオキシ基、i-プロポキシ基、i-ブトキシ基、s-ブトキシ基、t-ブトキシ基、i-ヘキシルオキシ基、3,3-ジメチルブトキシ基、イソペンチルオキシ基、ネオペンチルオキシ基、2,3,3-トリメチルブトキシ基、(4,4-ジメチルペンタン-2-イル)オキシ基などが挙げられる。 The “C1-6 alkoxy group” in X 1 is a methoxy group, ethoxy group, n-propoxy group, n-butoxy group, n-pentyloxy group, n-hexyloxy group, i-propoxy group, i-butoxy group , S-butoxy group, t-butoxy group, i-hexyloxy group, 3,3-dimethylbutoxy group, isopentyloxy group, neopentyloxy group, 2,3,3-trimethylbutoxy group, (4,4- And dimethylpentan-2-yl) oxy group.
「置換基を有するC1~6アルコキシ基」において、置換基としては、ハロゲノ基、C3~8シクロアルキル基、ヒドロキシ基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C6~10アリール基、3~6ヘテロシクリル基、C1~6アルコキシカルボニル基、C1~6アルキル置換アミノ基、C1~6アルキルチオ基、C1~6アルキルスルフィニル基、C1~6アルキルスルホニル基、シアノ基、C1~6アルキル置換シリル基などが挙げられる。 In the “substituted C1-6 alkoxy group”, examples of the substituent include a halogeno group, a C3-8 cycloalkyl group, a hydroxy group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, a C6-10 aryl group, 3-6 heterocyclyl group, C1-6 alkoxycarbonyl group, C1-6 alkyl substituted amino group, C1-6 alkylthio group, C1-6 alkylsulfinyl group, C1-6 alkylsulfonyl group, cyano group, C1-6 alkyl substituted silyl Groups and the like.
具体的な「置換基を有するC1~6アルコキシ基」としては、クロロメトキシ基、ジクロロメトキシ基、ジフルオロメトキシ基、トリクロロメトキシ基、トリフルオロメトキシ基、1-フルオロエトキシ基、1,1-ジフルオロエトキシ基、2,2,2-トリフルオロエトキシ基、ペンタフルオロエトキシ基、2,2,3,3-テトラフルオロプロポキシ基、2,2,3,3,3-ペンタフルオロプロポキシ基、1,1,2,3,3,3-ヘキサフルオロプロポキシ基、4,4,4-トリフルオロブトキシ基、2,2,3,4,4,4-ヘキサフルオロブトキシ基、2,2,3,3,4,4-ヘキサフルオロブトキシ基、2,2,3,3,4,4,4-ヘプタフルオロブトキシ基、3,4,4,4-テトラフルオロ-3-(トリフルオロメチル)ブトキシ基、(5,5,5-トリフルオロペンチル)オキシ基、(4,4,5,5,5-ペンタフルオロペンチル)オキシ基、(2,2,3,3,4,4,5,5-オクタフルオロペンチル)オキシ基、(2,2,3,3,4,4,5,5,5-ノナフルオロペンチル)オキシ基、(2,2,3,3,4,4,5,5,6,6,6-ウンデカフルオロヘキシル)オキシ基などのC1~6ハロアルコキシ基; Specific examples of the “substituted C1-6 alkoxy group” include chloromethoxy group, dichloromethoxy group, difluoromethoxy group, trichloromethoxy group, trifluoromethoxy group, 1-fluoroethoxy group, 1,1-difluoroethoxy. Group, 2,2,2-trifluoroethoxy group, pentafluoroethoxy group, 2,2,3,3-tetrafluoropropoxy group, 2,2,3,3,3-pentafluoropropoxy group, 1,1, 2,3,3,3-hexafluoropropoxy group, 4,4,4-trifluorobutoxy group, 2,2,3,4,4,4-hexafluorobutoxy group, 2,2,3,3,4 , 4-Hexafluorobutoxy group, 2,2,3,3,4,4,4-heptafluorobutoxy group, 3,4,4,4-tetrafluoro-3- (trifluoromethyl ) Butoxy group, (5,5,5-trifluoropentyl) oxy group, (4,4,5,5,5-pentafluoropentyl) oxy group, (2,2,3,3,4,4,5) , 5-octafluoropentyl) oxy group, (2,2,3,3,4,4,5,5,5-nonafluoropentyl) oxy group, (2,2,3,3,4,4,5 , 5,6,6,6-undecafluorohexyl) oxy group and other C1-6 haloalkoxy groups;
シクロプロピルメトキシ基、2-シクロプロピルエトキシ基、シクロペンチルメトキシ基、シクロヘキシルメトキシ基、2-シクロヘキシルエトキシ基などのC3~8シクロアルキルC1~6アルコキシ基;(2,2-ジフルオロシクロプロピル)メトキシ基などの、置換基としてハロゲノ基を有するC3~8シクロアルキルC1~6アルコキシ基;(2-メチルシクロプロピル)メトキシ基などの、置換基としてC1~6アルキル基を有するC3~8シクロアルキルC1~6アルコキシ基; C3-8 cycloalkyl C1-6 alkoxy groups such as cyclopropylmethoxy group, 2-cyclopropylethoxy group, cyclopentylmethoxy group, cyclohexylmethoxy group, 2-cyclohexylethoxy group; (2,2-difluorocyclopropyl) methoxy group, etc. A C3-8 cycloalkyl C1-6 alkoxy group having a halogeno group as a substituent; a C3-8 cycloalkyl C1-6 having a C1-6 alkyl group as a substituent, such as a (2-methylcyclopropyl) methoxy group An alkoxy group;
3-ヒドロキシ-3-メチルブトキシ基などのヒドロキシC1~6アルコキシ基;2-エトキシエトキシ基、3-メトキシ-3-メチルブトキシ基、2-(t-ブトキシ)エトキシ基などのC1~6アルコキシC1~6アルコキシ基;トリフルオロメトキシメトキシ基、トリフルオロメトキシエトキシ基などのC1~6ハロアルコキシC1~6アルコキシ基; Hydroxy C1-6 alkoxy groups such as 3-hydroxy-3-methylbutoxy group; C1-6 alkoxy C1 such as 2-ethoxyethoxy group, 3-methoxy-3-methylbutoxy group, 2- (t-butoxy) ethoxy group -6 alkoxy group; C1-6 haloalkoxy C1-6 alkoxy group such as trifluoromethoxymethoxy group and trifluoromethoxyethoxy group;
ベンジルオキシ基、フェネトキシ基、3-フェニルプロポキシ基などのC6~10アリールC1~6アルコキシ基;
(4-メチルベンジル)オキシ基、(4-メトキシベンジル)オキシ基、(4-トリフルオロベンジル)オキシ基、(4-フルオロベンジル)オキシ基などの、置換基としてC1~6アルキル基、C1~6アルコキシ基、C1~6ハロアルキル基、またはハロゲノ基の有するC6~10アリールC1~6アルコキシ基;
 (オキセタン-3-イル)メトキシ基、(テトラヒドロフラン-2-イル)メトキシ基、(ピリジン-2-イル)メトキシ基、(ピリジン-3-イル)メトキシ基、2-(ピリジン-2-イル)エトキシ基、3-(ピリジン-2-イル)プロポキシ基などの3~6員ヘテロシクリルC1~6アルコキシ基;(3-メチルオキセタン-3-イル)メトキシ基、(6-クロロピリジン-3-イル)メトキシ基、2-(3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル)エトキシ基、3-(3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル)プロポキシ基などの、置換基としてC1~6アルキル基、C1~6アルコキシ基、C1~6ハロアルキル基、またはハロゲノ基の有する3~6員ヘテロシクリルC1~6アルコキシ基;
A C6-10 aryl C1-6 alkoxy group such as benzyloxy group, phenoxy group, 3-phenylpropoxy group;
(4-methylbenzyl) oxy group, (4-methoxybenzyl) oxy group, (4-trifluorobenzyl) oxy group, (4-fluorobenzyl) oxy group, etc. A C6-10 aryl C1-6 alkoxy group having a 6 alkoxy group, a C1-6 haloalkyl group, or a halogeno group;
(Oxetane-3-yl) methoxy group, (tetrahydrofuran-2-yl) methoxy group, (pyridin-2-yl) methoxy group, (pyridin-3-yl) methoxy group, 2- (pyridin-2-yl) ethoxy Groups, 3- to 6-membered heterocyclyl C1-6 alkoxy groups such as 3- (pyridin-2-yl) propoxy group; (3-methyloxetan-3-yl) methoxy group, (6-chloropyridin-3-yl) methoxy Groups such as 2- (3-chloro-5- (trifluoromethyl) pyridin-2-yl) ethoxy group, 3- (3-chloro-5- (trifluoromethyl) pyridin-2-yl) propoxy group, 3- to 6-membered heterocyclyl C1-6 alkoxy having a C1-6 alkyl group, C1-6 alkoxy group, C1-6 haloalkyl group, or halogeno group as a substituent ;
2-(エトキシカルボニル)エトキシ基などのC1~6アルコキシカルボニルC1~6アルコキシ基;(1-(ジメチルアミノ)プロパン-2-イル)オキシ基、2-(ジメチルアミノ)エトキシ基などのC1~6アルキル置換アミノC1~6アルコキシ基;3-(メチルチオ)プロポキシ基などのC1~6アルキルチオC1~6アルコキシ基;3-(メチルスルフィニル)プロポキシ基などのC1~6アルキルスルフィニルC1~6アルコキシ基;3-(メチルスルホニル)プロポキシ基などのC1~6アルキルスルホニルC1~6アルコキシ基;2-シアノ-2-メチルプロポキシ基などのシアノC1~6アルコキシ基;3-(トリメチルシリル)プロポキシ基などのトリC1~6アルキル置換シリルC1~6アルコキシ基;などが挙げられる。 C1-6 alkoxycarbonyl such as 2- (ethoxycarbonyl) ethoxy group C1-6 alkoxy group; C1-6 such as (1- (dimethylamino) propan-2-yl) oxy group, 2- (dimethylamino) ethoxy group Alkyl substituted amino C1-6 alkoxy group; C1-6 alkylthio C1-6 alkoxy group such as 3- (methylthio) propoxy group; C1-6 alkylsulfinyl C1-6 alkoxy group such as 3- (methylsulfinyl) propoxy group; 3 A C1-6 alkylsulfonyl C1-6 alkoxy group such as a-(methylsulfonyl) propoxy group; a cyano C1-6 alkoxy group such as a 2-cyano-2-methylpropoxy group; a triC1-6 such as a 3- (trimethylsilyl) propoxy group 6 alkyl substituted silyl C1-6 alkoxy groups; It is.
 X1における「C2~6アルケニルオキシ基」としては、ビニルオキシ基、1-プロペニルオキシ基、2-プロペニルオキシ基(アリルオキシ基)、(3-メチルブテ-2-エン-1-イル)オキシ基などが挙げられる。
 「置換基を有するC2~6アルケニルオキシ基」としては、(2,3,3-トリフルオロアリル)オキシ基、(3,4,4-トリフルオロブト-3-エン-1-イル)オキシ基などのC2~6ハロアルケニルオキシ基; (3-フェニルアリル)オキシ基などのC6~10アリールC2~6アルケニルオキシ基; などが挙げられる。
Examples of the “C2-6 alkenyloxy group” in X 1 include a vinyloxy group, 1-propenyloxy group, 2-propenyloxy group (allyloxy group), (3-methylbut-2-en-1-yl) oxy group and the like. Can be mentioned.
Examples of the “substituted C2-6 alkenyloxy group” include (2,3,3-trifluoroallyl) oxy group, (3,4,4-trifluorobut-3-en-1-yl) oxy group C2-6 haloalkenyloxy groups such as; C6-C10 aryl C2-6 alkenyloxy groups such as (3-phenylallyl) oxy group; and the like.
 X1における「C2~6アルキニルオキシ基」としては、エチニルオキシ基、プロピ-2-イン-1-イルオキシ基、ブチ-2-イン-1-イルオキシ基などが挙げられる。
 「置換基を有するC2~6アルキニルオキシ基」としては、4,4-ジクロロ-1-ブチニルオキシ基、4-フルオロ-1-ペンチニルオキシ基、5-ブロモ-2-ペンチニルオキシ基などのC2~6ハロアルキニルオキシ基; (3-フェニルプロピ-2-イン-1-イル)オキシ基などのC6~10アリールC2~6アルキニルオキシ基; などが挙げられる。
Examples of the “C2-6 alkynyloxy group” for X 1 include ethynyloxy group, prop-2-yn-1-yloxy group, but-2-yn-1-yloxy group and the like.
Examples of the “substituted C2-6 alkynyloxy group” include C2 such as 4,4-dichloro-1-butynyloxy group, 4-fluoro-1-pentynyloxy group, 5-bromo-2-pentynyloxy group, etc. To 6 haloalkynyloxy groups; C6-C10 aryl C2-6 alkynyloxy groups such as (3-phenylprop-2-yn-1-yl) oxy group;
 X1における「C3~8シクロアルキルオキシ基」としては、シクロプロピルオキシ基、シクロブチルオキシ基、シクロペンチルオキシ基、シクロヘキシルオキシ基などが挙げられる。
 「置換基を有するC3~8シクロアルキルオキシ基」としては、(4,4-ジフルオロシクロヘキシル)オキシ基などのC3~8ハロシクロアルキルオキシ基などが挙げられる。
Examples of the “C3-8 cycloalkyloxy group” for X 1 include a cyclopropyloxy group, a cyclobutyloxy group, a cyclopentyloxy group, a cyclohexyloxy group, and the like.
Examples of the “substituted C3-8 cycloalkyloxy group” include C3-8 halocycloalkyloxy groups such as (4,4-difluorocyclohexyl) oxy group.
 X1における「C1~7アシル基」としては、ホルミル基、アセチル基、プロピオニル基、ベンゾイル基などが挙げられる。
 「置換基を有するC1~7アシル基」としては、クロロアセチル基、トリフルオロアセチル基、トリクロロアセチル基、4-クロロベンゾイル基などのC1~7ハロアシル基などが挙げられる。
Examples of the “C1-7 acyl group” in X 1 include formyl group, acetyl group, propionyl group, benzoyl group and the like.
Examples of the “substituted C1-7 acyl group” include C1-7 haloacyl groups such as a chloroacetyl group, a trifluoroacetyl group, a trichloroacetyl group, and a 4-chlorobenzoyl group.
 X1における「C1~6アルコキシカルボニル基」としては、メトキシカルボニル基、エトキシカルボニル基、n-プロポキシカルボニル基、i-プロポキシカルボニル基などが挙げられる。
 「置換基を有するC1~6アルコキシカルボニル基」としては、
 シクロプロピルメトキシカルボニル基、シクロブチルメトキシカルボニル基、シクロペンチルメトキシカルボニル基、シクロヘキシルメトキシカルボニル基、2-メチルシクロプロピルメトキシカルボニル基、2,3-ジメチルシクロプロピルメトキシカルボニル基、2-クロロシクロプロピルメトキシカルボニル基、2-シクロプロピルエトキシカルボニル基などのC3~8シクロアルキルC1~6アルコキシカルボニル基; フルオロメトキシカルボニル基、クロロメトキシカルボニル基、ブロモメトキシカルボニル基、ジフルオロメトキシカルボニル基、ジクロロメトキシカルボニル基、ジブロモメトキシカルボニル基、トリフルオロメトキシカルボニル基、トリクロロメトキシカルボニル基、トリブロモメトキシカルボニル基、2,2,2-トリフルオロエトキシカルボニル基、2,2,2-トリクロロエトキシカルボニル基、ペンタフルオロエトキシカルボニル基、4-フルオロブトキシカルボニル基、3,3,3-トリフルオロプロポキシカルボニル基、2,2,2-トリフルオロ-1-トリフルオロメチルエトキシカルボニル基、パーフロロヘキシルオキシカルボニル基などのC1~6ハロアルコキシカルボニル基;などが挙げられる。
Examples of the “C1-6 alkoxycarbonyl group” for X 1 include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, and the like.
As the “C1-6 alkoxycarbonyl group having a substituent”,
Cyclopropylmethoxycarbonyl group, cyclobutylmethoxycarbonyl group, cyclopentylmethoxycarbonyl group, cyclohexylmethoxycarbonyl group, 2-methylcyclopropylmethoxycarbonyl group, 2,3-dimethylcyclopropylmethoxycarbonyl group, 2-chlorocyclopropylmethoxycarbonyl group C3-8 cycloalkyl C1-6 alkoxycarbonyl groups such as 2-cyclopropylethoxycarbonyl group; fluoromethoxycarbonyl group, chloromethoxycarbonyl group, bromomethoxycarbonyl group, difluoromethoxycarbonyl group, dichloromethoxycarbonyl group, dibromomethoxycarbonyl Group, trifluoromethoxycarbonyl group, trichloromethoxycarbonyl group, tribromomethoxycarbonyl group, 2,2 , 2-trifluoroethoxycarbonyl group, 2,2,2-trichloroethoxycarbonyl group, pentafluoroethoxycarbonyl group, 4-fluorobutoxycarbonyl group, 3,3,3-trifluoropropoxycarbonyl group, 2,2,2 A C1-6 haloalkoxycarbonyl group such as a trifluoro-1-trifluoromethylethoxycarbonyl group or a perfluorohexyloxycarbonyl group;
 Xにおける「C1~6アルキルカルバモイル基」としては、メチルカルバモイル基、エチルカルバモイル基などが挙げられる。
 「置換基を有するC1~6アルキルカルバモイル基」としては、(2,2,2-トリフルオロエチル)カルバモイル基などのC1~6ハロアルキルカルバモイル基などが挙げられる。
Examples of the “C1-6 alkylcarbamoyl group” for X 1 include a methylcarbamoyl group, an ethylcarbamoyl group, and the like.
Examples of the “substituted C1-6 alkylcarbamoyl group” include C1-6 haloalkylcarbamoyl groups such as a (2,2,2-trifluoroethyl) carbamoyl group.
 X1における「置換基を有するアミノ基」としては、メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基、イソペンチルアミノ基、イソペンチル(メチル)アミノ基などのC1~6アルキル置換アミノ基;(2,2,3,3,4,4,4-ヘプタフルオロブチル)アミノ基などのC1~6ハロアルキル置換アミノ基;などが挙げられる。 As the “amino group having a substituent” for X 1 , a C1-6 alkyl-substituted amino group such as a methylamino group, a dimethylamino group, a diethylamino group, an isopentylamino group, an isopentyl (methyl) amino group; , 3,3,4,4,4-heptafluorobutyl) amino group and the like, and the like.
 X1における「C1~6アルキルチオ基」としては、メチルチオ基、エチルチオ基、n-プロピルチオ基、n-ブチルチオ基、n-ペンチルチオ基、n-ヘキシルチオ基、i-プロピルチオ基、イソペンチルチオ基などが挙げられる。 Examples of the “C1-6 alkylthio group” in X 1 include methylthio group, ethylthio group, n-propylthio group, n-butylthio group, n-pentylthio group, n-hexylthio group, i-propylthio group, isopentylthio group and the like. Can be mentioned.
における「C1~6アルキルスルフィニル基」しては、メチルスルフィニル基、エチルスルフィニル基、t-ブチルスルフィニル基、イソペンチルスルフィニル基などが挙げられる。 Examples of the “C1-6 alkylsulfinyl group” in X 1 include a methylsulfinyl group, an ethylsulfinyl group, a t-butylsulfinyl group, and an isopentylsulfinyl group.
 X1における「C1~6アルキルスルホニル基」としては、メチルスルホニル基、エチルスルホニル基、t-ブチルスルホニル基、イソペンチルスルホニル基などが挙げられる。 Examples of the “C1-6 alkylsulfonyl group” for X 1 include a methylsulfonyl group, an ethylsulfonyl group, a t-butylsulfonyl group, an isopentylsulfonyl group, and the like.
 X1における「C6~10アリール基」は、単環および多環のいずれであってもよい。多環アリール基は、少なくとも一つの環が芳香環であれば、残りの環が飽和脂環、不飽和脂環または芳香環のいずれであってもよい。
 「C6~10アリール基」としては、フェニル基、ナフチル基、アズレニル基、インデニル基、インダニル基、テトラリニル基などが挙げられる。
The “C6-10 aryl group” for X 1 may be monocyclic or polycyclic. In the polycyclic aryl group, if at least one ring is an aromatic ring, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring.
Examples of the “C6-10 aryl group” include phenyl group, naphthyl group, azulenyl group, indenyl group, indanyl group, tetralinyl group and the like.
 X1における「3~6員ヘテロシクリル基」は、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1~4個のヘテロ原子を環の構成原子として含む。ヘテロシクリル基は、単環および多環のいずれであってもよい。多環ヘテロシクリル基は、少なくとも一つの環がヘテロシクリルであれば、残りの環が飽和脂環、不飽和脂環または芳香環のいずれであってもよい。「3~6員ヘテロシクリル基」としては、3員~6員飽和へテロシクリル基、5員~6員ヘテロアリール基、5~6員部分不飽和へテロシクリル基などが挙げられる。 The “3- to 6-membered heterocyclyl group” in X 1 includes 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom, and a sulfur atom as ring constituent atoms. The heterocyclyl group may be monocyclic or polycyclic. In the polycyclic heterocyclyl group, when at least one ring is heterocyclyl, the remaining ring may be a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the “3- to 6-membered heterocyclyl group” include a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, and a 5- to 6-membered partially unsaturated heterocyclyl group.
 3~6員飽和ヘテロシクリル基としては、アジリジニル基、オキシラニル基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、ピペリジル基、ピペラジニル基、モルホリニル基、ジオキソラニル基、ジオキサニル基などが挙げられる。 Examples of the 3- to 6-membered saturated heterocyclyl group include aziridinyl group, oxiranyl group, azetidinyl group, oxetanyl group, pyrrolidinyl group, tetrahydrofuranyl group, piperidyl group, piperazinyl group, morpholinyl group, dioxolanyl group, dioxanyl group and the like.
 5員ヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などが挙げられる。
 6員ヘテロアリール基としては、ピリジル基、ピラジニル基、ピリミジニル基、ピリダニジル基、トリアジニル基などが挙げられる。
Examples of the 5-membered heteroaryl group include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, etc. .
Examples of the 6-membered heteroaryl group include a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridanidyl group, and a triazinyl group.
 部分不飽和の5員ヘテロシクリル基としては、ピロリニル基、イミダゾリニル基(ジヒドロイミダゾリニル基)、ピラゾリニル基、オキサゾリニル基、イソオキサゾリニル基、チアゾリニル基などが挙げられる。
 部分不飽和の6員ヘテロシクリル基としては、チオピラニル基、2H-ピリジン-1-イル基、4H-ピリジン-1-イル基などが挙げられる。
Examples of the partially unsaturated 5-membered heterocyclyl group include pyrrolinyl group, imidazolinyl group (dihydroimidazolinyl group), pyrazolinyl group, oxazolinyl group, isoxazolinyl group, thiazolinyl group and the like.
Examples of the partially unsaturated 6-membered heterocyclyl group include a thiopyranyl group, a 2H-pyridin-1-yl group, and a 4H-pyridin-1-yl group.
 「C6~10アリール基」および「3~6員ヘテロシクリル基」上の置換基としては、C1~6アルキル基、ヒドロキシ基、C1~6アルコキシ基、ハロゲノ基、シアノ基、ニトロ基、C1~6ハロアルキル基などが挙げられる。 Substituents on “C6-10 aryl group” and “3-6 membered heterocyclyl group” include C1-6 alkyl group, hydroxy group, C1-6 alkoxy group, halogeno group, cyano group, nitro group, C1-6 And a haloalkyl group.
1における「C6~10アリールオキシ基」としては、フェノキシ基、1-ナフトキシ基などが挙げられる。
 「C6~10アリールオキシ基」上の置換基としては、C1~6アルキル基、ヒドロキシ基、C1~6アルコキシ基、ハロゲノ基、シアノ基、ニトロ基、C1~6ハロアルキル基などが挙げられる。
Examples of the “C6-10 aryloxy group” for X 1 include a phenoxy group and a 1-naphthoxy group.
Examples of the substituent on the “C6-10 aryloxy group” include a C1-6 alkyl group, a hydroxy group, a C1-6 alkoxy group, a halogeno group, a cyano group, a nitro group, and a C1-6 haloalkyl group.
 X1における「ハロゲノ基」としては、フルオロ基、クロロ基、ブロモ基、イオド基などが挙げられる。 Examples of the “halogeno group” for X 1 include a fluoro group, a chloro group, a bromo group, and an iodo group.
 X1としては、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するアミノ基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、ハロゲノ基、シアノ基、またはニトロ基であることが好ましい。 X 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, an unsubstituted Or a substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group C1-6 alkoxycarbonyl group, unsubstituted or substituted amino group, unsubstituted or substituted C1-6 alkylthio group, unsubstituted or substituted C1-6 alkylsulfonyl group, unsubstituted Or a substituted C6-10 aryl group, an unsubstituted or substituted 3-6 membered heterocyclyl group, a halo Amino group is preferably a cyano group or a nitro group.
 Xとしては、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC2~6アルケニルオキシ基、無置換のもしくは置換基を有するC2~6アルキニルオキシ基、無置換のもしくは置換基を有するC3~8シクロアルキルオキシ基、無置換のもしくは置換基を有するC1~6アルキルカルバモイル基、無置換のもしくは置換基を有するアミノ基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、または無置換のもしくは置換基を有するC6~10アリールオキシ基であることがより好ましい。 X 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C2-6 alkenyloxy group, unsubstituted Or a substituted C2-6 alkynyloxy group, an unsubstituted or substituted C3-8 cycloalkyloxy group, an unsubstituted or substituted C1-6 alkylcarbamoyl group, an unsubstituted or substituted group An unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted 3-6 membered heterocyclyl group, or an unsubstituted or substituted C6-10 aryloxy group More preferably.
 Xとしては、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC1~6アルキルチオ基、または無置換のもしくは置換基を有する3~6員飽和ヘテロシクリル基であることがより好ましい。
「置換基を有するC1~6アルキル基」において、置換基としては、ハロゲノ基、またはC3~8シクロアルキル基などが好ましい。
「置換基を有するC1~6アルコキシ基」において、置換基としては、C1~6アルキル基、ヒドロキシ基、C1~6アルコキシ基、C1~6アルキルチオ基、C6~10アリール基、3~6員ヘテロシクリル基、C1~6アルキル3~6員ヘテロシクリル基、ハロゲノ基、シアノ基、C3~8シクロアルキル基、ハロC3~8シクロアルキル基、またはC1~6アルキルC3~8シクロアルキル基などが好ましい。
「置換基を有するC1~6アルキルカルバモイル基」において、置換基としては、ハロゲノ基などが好ましい。
「置換基を有するアミノ基」において、置換基としては、C1~6アルキル基などが好ましい。
「置換基を有する3~6員飽和ヘテロシクリル基」において、置換基としては、C1~6アルキル基、ハロゲノ基、シアノ基、C1~6ハロアルキル基などが好ましい。
詳しくは、Xとしては、C1~6アルキル基、C1~6ハロアルキル基、C1~6アルコキシ基、C1~6ハロアルコキシ基、C3~8シクロアルキルC1~6アルコキシ基、C1~6アルキルチオ基、または3~6員飽和ヘテロシクリル基であることが好ましい。
X 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-6 alkylthio group, or an unsubstituted group. Or a 3- to 6-membered saturated heterocyclyl group having a substituent.
In the “C1-6 alkyl group having a substituent”, the substituent is preferably a halogeno group or a C3-8 cycloalkyl group.
In the “substituted C1-6 alkoxy group”, examples of the substituent include a C1-6 alkyl group, a hydroxy group, a C1-6 alkoxy group, a C1-6 alkylthio group, a C6-10 aryl group, and a 3-6 membered heterocyclyl. Group, C1-6 alkyl 3-6 membered heterocyclyl group, halogeno group, cyano group, C3-8 cycloalkyl group, halo C3-8 cycloalkyl group, C1-6 alkyl C3-8 cycloalkyl group and the like are preferable.
In the “C1-6 alkylcarbamoyl group having a substituent”, the substituent is preferably a halogeno group or the like.
In the “amino group having a substituent”, the substituent is preferably a C1-6 alkyl group and the like.
In the “3- to 6-membered saturated heterocyclyl group having a substituent”, the substituent is preferably a C1-6 alkyl group, a halogeno group, a cyano group, a C1-6 haloalkyl group, or the like.
Specifically, as the X 1, C1 ~ 6 alkyl group, C1 ~ 6 haloalkyl group, C1 ~ 6 alkoxy group, C1 ~ 6 haloalkoxy group, C3 ~ 8 cycloalkyl C1 ~ 6 alkoxy group, C1 ~ 6 alkylthio group, Or, it is preferably a 3- to 6-membered saturated heterocyclyl group.
〔A〕
 Aは、炭素原子または窒素原子を示す。Aは、窒素原子であることが好ましい。
[A]
A represents a carbon atom or a nitrogen atom. A is preferably a nitrogen atom.
〔X2、n〕
 X2は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するアミノ基、メルカプト基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、ハロゲノ基、シアノ基、またはニトロ基を示す。
 nは、X2の個数を示しかつ0~3のいずれかの整数である。nが2以上のときX2は互いに同一でも異なっていてもよい。
[X 2, n]
X 2 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group A C1-6 alkoxycarbonyl group, an unsubstituted or substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfonyl group, Unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl Shows a halogeno group, a cyano group or a nitro group.
n represents the number of X 2 and is an integer from 0 to 3. When n is 2 or more, X 2 may be the same as or different from each other.
 X2における「C1~6アルキル基」、「C2~6アルケニル基」、「C2~6アルキニル基」、「C3~8シクロアルキル基」、「C1~6アルコキシ基」、「C1~7アシル基」、「C1~6アルコキシカルボニル基」、「アミノ基」、「C1~6アルキルチオ基」、「C1~6アルキルスルホニル基」、「C6~10アリール基」、「3~6員ヘテロシクリル基」、および「ハロゲノ基」ならびにこれらの基に置換基を有する基としては、前記X1において例示したそれらと同じものが挙げられる。 “C1-6 alkyl group”, “C2-6 alkenyl group”, “C2-6 alkynyl group”, “C3-8 cycloalkyl group”, “C1-6 alkoxy group”, “C1-7 acyl group” for X 2 ”,“ C1-6 alkoxycarbonyl group ”,“ amino group ”,“ C1-6 alkylthio group ”,“ C1-6 alkylsulfonyl group ”,“ C6-10 aryl group ”,“ 3-6 membered heterocyclyl group ”, Examples of the “halogeno group” and the group having a substituent in these groups are the same as those exemplified for X 1 above.
〔R1
 R1は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、無置換のもしくは置換基を有するC6~10アリール基、または無置換のもしくは置換基を有する3~6員ヘテロシクリル基を示す。
[R 1 ]
R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted 3-6 membered heterocyclyl group is shown.
 R1における「C1~6アルキル基」、「C2~6アルケニル基」、「C2~6アルキニル基」、「C3~8シクロアルキル基」、「C6~10アリール基」、および「3~6員ヘテロシクリル基」、ならびにこれらの基に置換基を有する基としては、前記X1において例示したそれらと同じものが挙げられる。
1としては、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、または無置換のもしくは置換基を有するC2~6アルキニル基であることが好ましい。
「置換基を有するC1~6アルキル基」において、置換基としては、C3~8シクロアルキル基、またはハロゲノ基などが好ましい。
“C1-6 alkyl group”, “C2-6 alkenyl group”, “C2-6 alkynyl group”, “C3-8 cycloalkyl group”, “C6-10 aryl group”, and “3-6 members” in R 1 Examples of the “heterocyclyl group” and the group having a substituent in these groups include the same groups as those exemplified above for X 1 .
R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, or an unsubstituted or substituted C2-6 alkynyl group. Is preferred.
In the “C1-6 alkyl group having a substituent”, the substituent is preferably a C3-8 cycloalkyl group or a halogeno group.
式(I)中、交差した実線で表した結合は、立体異性を有する二重結合(undefined double stereo bond)を示す。
 この二重結合によって、本発明のアゾリルオキシム化合物またはその塩には、式(I)中のオキシム構造に由来する二重結合の立体異性体である、E異性体若しくはZ異性体、またはE異性体とZ異性体の混合物が含まれる。
In the formula (I), a bond represented by crossed solid lines represents a double bond having stereoisomerism (undefined double stereo bond).
By this double bond, the azolyl oxime compound of the present invention or a salt thereof has an E isomer or a Z isomer, or an E isomer, which is a stereoisomer of a double bond derived from the oxime structure in the formula (I). And a mixture of Z isomers.
 本発明のアゾリルオキシム化合物は、式(II)で表されるアゾリルオキシム化合物(以下、化合物(II)と表記することがある。)であることが好ましい。
Figure JPOXMLDOC01-appb-C000008
式(II)中、X1、A、X2、n、R1、および交差した実線で表した結合は、前記のとおりである。
The azolyl oxime compound of the present invention is preferably an azolyl oxime compound represented by formula (II) (hereinafter sometimes referred to as compound (II)).
Figure JPOXMLDOC01-appb-C000008
In formula (II), X 1 , A, X 2 , n, R 1 and the bond represented by the crossed solid line are as described above.
〔X11、m1〕
式(II)中、X11は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するアミノ基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルフィニル基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、ハロゲノ基、シアノ基、またはニトロ基を示す。
 m1は、X11の個数を示しかつ0~2のいずれかの整数である。m1が2以上のときX11は互いに同一でも異なっていてもよい。
[X 11, m1]
In the formula (II), X 11 represents an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl Group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted amino group, unsubstituted or substituted A C1-6 alkylthio group having a group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1-6 alkylsulfonyl group, a halogeno group, a cyano group, or a nitro group .
m1 represents the number of X 11 and is an integer from 0 to 2. When m1 is 2 or more, X 11 may be the same as or different from each other.
11における「C1~6アルキル基」、「C2~6アルケニル基」、「C2~6アルキニル基」、「C3~8シクロアルキル基」、「C1~6アルコキシ基」、「アミノ基」、「C1~6アルキルチオ基」、「C1~6アルキルスルフィニル基」、「C1~6アルキルスルホニル基」、および「ハロゲノ基」ならびにこれらの基に置換基を有する基としては、前記X1において例示したそれらと同じものが挙げられる。 "C1 ~ 6 alkyl group" in X 11, "C2 ~ 6 alkenyl group", "C2 ~ 6 alkynyl group", "C3 ~ 8 cycloalkyl group", "C1 ~ 6 alkoxy group", "amino group", " “C1-6 alkylthio group”, “C1-6 alkylsulfinyl group”, “C1-6 alkylsulfonyl group”, “halogeno group” and groups having substituents on these groups include those exemplified in the above X 1 The same thing is mentioned.
 X11としては、無置換の若しくは置換基を有するC1~6アルキル基、無置換の若しくは置換基を有するC1~6アルコキシ基、またはハロゲノ基であることが好ましい。
 X11としては、ハロゲノ基またはシアノ基であることがより好ましい。
 m1は、0または1のいずれかの整数であることが好ましい。
X 11 is preferably an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C1-6 alkoxy group, or a halogeno group.
X 11 is more preferably a halogeno group or a cyano group.
m1 is preferably an integer of 0 or 1.
 本発明のアゾリルオキシム化合物は、式(III)で表されるアゾリルオキシム化合物(以下、化合物(III)と表記することがある。)も挙げることができる。 Examples of the azolyl oxime compound of the present invention include an azolyl oxime compound represented by the formula (III) (hereinafter sometimes referred to as compound (III)).
Figure JPOXMLDOC01-appb-C000009
Figure JPOXMLDOC01-appb-C000009
式(III)中、X1、A、X2、n、R1、および交差した実線で表した結合は、前記のとおりである。
式(III)中、X11、およびm1は前記のとおりである。
In the formula (III), X 1 , A, X 2 , n, R 1 , and the bond represented by the crossed solid line are as described above.
In the formula (III), X 11 and m1 are as described above.
 本発明のアゾリルオキシム化合物の塩は、化合物(I)~化合物(III)のいずれの化合物の塩である。塩としては、農園芸学的に許容される塩であれば、特に制限されない。例えば、塩酸、硫酸などの無機酸の塩;酢酸、乳酸などの有機酸の塩;リチウム、ナトリウム、カリウムなどのアルカリ金属の塩;カルシウム、マグネシウムなどのアルカリ土類金属の塩;鉄、銅などの遷移金属の塩;アンモニア、トリエチルアミン、トリブチルアミン、ピリジン、ヒドラジンなどの有機塩基の塩などが挙げられる。アゾリルオキシム化合物の塩は、公知の手法によって得ることができる。 The salt of the azolyl oxime compound of the present invention is a salt of any of the compounds (I) to (III). The salt is not particularly limited as long as it is an agro-horticulturally acceptable salt. For example, salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; iron and copper And salts of organic bases such as ammonia, triethylamine, tributylamine, pyridine and hydrazine. The salt of the azolyl oxime compound can be obtained by a known method.
 本発明のアゾリルオキシム化合物およびその塩は、その製造方法によって特に限定されない。本発明のアゾリルオキシム化合物およびその塩は、実施例等に記載した公知の製造方法によって得ることができる。 The azolyloxime compound and the salt thereof of the present invention are not particularly limited by the production method. The azolyl oxime compound and its salt of the present invention can be obtained by known production methods described in Examples and the like.
〔有害生物防除剤〕
 本発明のアゾリルオキシム化合物またはその塩(以下「本発明化合物」ということがある。)は、植物の生育に影響する各種の農業害虫およびダニ類などの有害生物の防除効果に優れている。また、薬害が少なく、魚類や温血動物への毒性が低いため、安全性の高い化合物である。そのため、殺虫剤または殺ダニ剤の有効成分として有用である。
 さらに、近年、コナガ、ウンカ、ヨコバイ、アブラムシなど多くの害虫において有機リン剤、カーバメート剤に対する抵抗性が発達し、それら薬剤の効力不足問題を生じており、抵抗性系統の害虫にも有効な薬剤が望まれている。本発明化合物は感受性系統のみならず、各種抵抗性系統の害虫や、さらに殺ダニ剤抵抗性系統のダニ類にも優れた防除効果を示す。
[Pesticides]
The azolyl oxime compound of the present invention or a salt thereof (hereinafter sometimes referred to as “the compound of the present invention”) has an excellent pest control effect such as various agricultural pests and mites that affect plant growth. In addition, it is a highly safe compound due to its low phytotoxicity and low toxicity to fish and warm-blooded animals. Therefore, it is useful as an active ingredient of an insecticide or an acaricide.
Furthermore, in recent years, resistance to organophosphates and carbamates has been developed in many pests such as diamondback moth, leafhopper, leafhopper, and aphid, resulting in a lack of efficacy of these drugs. Is desired. The compound of the present invention exhibits an excellent control effect not only on susceptible strains but also on pests of various resistant strains, and further on mite-resistant strains of mites.
 また、本発明化合物は、広範囲の種類の糸状菌、例えば、藻菌類(Oomycetes)、子のう(嚢)菌類(Ascomycetes)、不完全菌類(Deuteromycetes)、担子菌類(Basidiomycetes)に属する菌などの植物病原菌の防除効果に優れる。そのため、殺菌剤の有効成分として有用である。 In addition, the compounds of the present invention can be used for a wide variety of filamentous fungi such as fungi belonging to algae (Oomycetes), Ascomycetes, Deuteromycetes, and basidiomycetes. Excellent control of plant pathogens. Therefore, it is useful as an active ingredient of a bactericide.
 本発明の有害生物防除剤は、本発明化合物から選ばれる少なくとも1つを有効成分として含有する。
 本発明の有害生物防除剤の処理の対象となる植物としては、穀物類、野菜類、根菜類、イモ類、樹木類、牧草類、芝類などが挙げられる。その場合、これら植物類の各部位を対象として処理することもできる。植物類の各部位としては、葉、茎、柄、花、蕾、果実、種子、スプラウト、根、塊茎、塊根、苗条、挿し木などが挙げられる。また、これら植物類の改良品種・変種、栽培品種、さらには突然変異体、ハイブリッド体、遺伝子組み換え体(GMO)を対象として処理することもできる。
The pest control agent of the present invention contains at least one selected from the compounds of the present invention as an active ingredient.
Examples of plants to be treated with the pest control agent of the present invention include cereals, vegetables, root vegetables, potatoes, trees, grasses, turf and the like. In that case, each part of these plants can also be processed. Examples of each part of the plant include leaves, stems, patterns, flowers, buds, fruits, seeds, sprout, roots, tubers, tuberous roots, shoots, cuttings, and the like. Further, improved varieties and varieties of these plants, cultivated varieties, and mutants, hybrids, and genetically modified organisms (GMO) can also be treated.
 本発明の有害生物防除剤は、各種の農業害虫およびダニ類を防除するため、さらには各種の植物病原菌を防除するために、種子処理、茎葉散布、土壌施用、水面施用などに使用することができる。 The pest control agent of the present invention can be used for seed treatment, foliage application, soil application, water surface application, etc. to control various agricultural pests and mites, and further to control various phytopathogenic fungi. it can.
 本発明の有害生物防除剤は、殺菌剤、殺虫・殺ダニ剤、殺線虫剤、殺土壌害虫剤、植物調節剤、共力剤、肥料、土壌改良剤、動物用飼料などと混用または併用してもよい。 The pest control agent of the present invention is used in combination or in combination with bactericides, insecticides / acaricides, nematicides, soil insecticides, plant regulators, synergists, fertilizers, soil conditioners, animal feeds, etc. May be.
 本発明化合物は、人獣に害を及ぼす外部寄生虫の防除効果に優れているため、外部寄生虫防除剤の有効成分として有用である。
 外部寄生虫としては、ダニ類、シラミ類、ノミ類などが挙げられる。
 本発明の外部寄生虫防除剤の処理の対象となる宿主動物としては、イヌ、ネコなどの愛玩動物;愛玩鳥;ウシ、ウマ、ブタ、ヒツジなどの家畜;家禽; などの温血動物が挙げられる。その他にも、ミツバチが挙げられる。
 外部寄生虫は、宿主動物、特には温血動物の中および上に寄生する。詳しくは、宿主動物の背、脇下、下腹部、内股部などに寄生して動物から血液やフケなどの栄養源を得て生息する。
 本発明の外部寄生虫防除剤は、公知の獣医学的な手法(局所、経口、非経口または皮下投与)で施用することができる。その方法として、錠剤、カプセル、飼料混入などにより動物に経口的に投与する方法; 浸漬液、坐薬、注射(筋肉内、皮下、静脈内、腹腔内など)などにより動物に投与する方法; 油性または水性液剤を噴霧、ポアオン、スポットオンなどにより局所的に投与する方法; 樹脂に外部寄生虫防除剤を練り込み、前記混練物を首輪、耳札などの適当な形状に成形し、それを動物に装着し局所的に投与する方法; などが挙げられる。
The compound of the present invention is useful as an active ingredient of an ectoparasite control agent because it is excellent in the control effect of ectoparasites harmful to humans.
Examples of ectoparasites include ticks, lice and fleas.
Examples of host animals to be treated with the ectoparasite control agent of the present invention include pets such as dogs and cats; pets; domestic animals such as cattle, horses, pigs, and sheep; It is done. In addition, a bee is mentioned.
Ectoparasites parasitize in and on host animals, particularly warm-blooded animals. Specifically, it infests the back, underarms, lower abdomen, and inner crotch of the host animal and obtains nutrients such as blood and dandruff from the animal.
The ectoparasite control agent of the present invention can be applied by a known veterinary technique (topical, oral, parenteral or subcutaneous administration). As the method, it is administered orally to animals by tablet, capsule, feed mixing, etc .; it is administered to animals by immersion liquid, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.); A method of locally administering an aqueous solution by spraying, pour-on, spot-on, etc .; kneading an ectoparasite-controlling agent into a resin, shaping the kneaded product into an appropriate shape such as a collar or ear tag, and applying it to an animal A method of wearing and administering locally;
〔製剤処方〕
 本発明の有害生物防除剤の製剤処方を若干示すが、添加物および添加割合は、これら実施例に限定されるべきものではなく、広範囲に変化させることが可能である。製剤処方中の部は質量部を示す。以下に農園芸用の製剤実施例を示す。
[Prescription formulation]
Although the pharmaceutical formulation of the pest control agent of the present invention is shown slightly, the additives and addition ratios are not limited to these examples, and can be varied in a wide range. The part in a formulation prescription shows a mass part. Examples of formulations for agricultural and horticultural use are shown below.
(製剤1:水和剤)
 本発明化合物            40部
 珪藻土               53部
 高級アルコール硫酸エステル      4部
 アルキルナフタレンスルホン酸塩    3部
 以上を均一に混合して微細に粉砕して、有効成分40%の水和剤を得た。
(Formulation 1: wettable powder)
Compound of the present invention 40 parts Diatomaceous earth 53 parts Higher alcohol sulfate 4 parts Alkyl naphthalene sulfonate 3 parts The above components were mixed uniformly and finely pulverized to obtain a wettable powder of 40% active ingredient.
(製剤2:乳剤)
 本発明化合物                 30部
 キシレン                   33部
 ジメチルホルムアミド             30部
 ポリオキシエチレンアルキルアリルエーテル    7部
 以上を混合溶解して、有効成分30%の乳剤を得た。
(Formulation 2: Emulsion)
Compound of the present invention 30 parts Xylene 33 parts Dimethylformamide 30 parts Polyoxyethylene alkylallyl ether 7 parts The above components were mixed and dissolved to obtain an emulsion containing 30% active ingredient.
(製剤3:粒剤)
本発明化合物         5部
タルク           40部
クレー           38部
ベントナイト        10部
アルキル硫酸ソーダ      7部
以上を均一に混合して微細に粉砕後、直径0.5~1.0mmの粒状に造粒して有効成分5%の粒剤を得る。
(Formulation 3: Granules)
Compound of the present invention 5 parts Talc 40 parts Clay 38 parts Bentonite 10 parts Sodium alkyl sulfate 7 parts or more are uniformly mixed and finely pulverized, then granulated into granules having a diameter of 0.5 to 1.0 mm and active ingredient 5% Get the granules.
(製剤4:粒剤)
本発明化合物                5部
クレー                   73部
ベントナイト                20部
ジオクチルスルホサクシネートナトリウム塩   1部
リン酸カリウム                1部
以上をよく粉砕混合し、水を加えてよく練り合せた後、造粒乾燥して有効成分5%の粒剤を得る。
(Formulation 4: Granules)
Compound of the present invention 5 parts Clay 73 parts Bentonite 20 parts Dioctylsulfosuccinate sodium salt 1 part Potassium phosphate 1 part or more is pulverized and mixed well, water is added and kneaded well, granulated and dried, and 5% active ingredient Get the granules.
(製剤5:懸濁剤)
本発明化合物                10部
ポリオキシエチレンアルキルアリルエーテル   4部
ポリカルボン酸ナトリウム塩          2部
グリセリン                 10部
キサンタンガム              0.2部
水                   73.8部
以上を混合し、粒度が3ミクロン以下になるまで湿式粉砕し、有効成分10%の懸濁剤を得る。
(Formulation 5: Suspension)
Compound of the present invention 10 parts polyoxyethylene alkyl allyl ether 4 parts polycarboxylic acid sodium salt 2 parts glycerin 10 parts xanthan gum 0.2 parts water 73.8 parts or more are mixed and wet milled until the particle size is 3 microns or less, A suspension with 10% active ingredient is obtained.
 以下に外部寄生虫防除剤の製剤処方を示す。 The formulation of ectoparasite control agent is shown below.
(製剤6:顆粒)
 本発明化合物      5部
 カオリン       94部
 ホワイトカーボン    1部
本発明化合物を有機溶媒中で溶解させ、担体上へ噴霧した後、溶媒を減圧下蒸発させる。この種の顆粒は動物の餌と混合できる。
(Formulation 6: Granules)
Compound of the present invention 5 parts Kaolin 94 parts White carbon 1 part The compound of the present invention is dissolved in an organic solvent, sprayed onto a carrier, and then the solvent is evaporated under reduced pressure. This type of granule can be mixed with animal food.
(製剤7:注入剤)
 本発明化合物   0.1~1部
 ラッカセイ油   バランス
調製後は、滅菌フィルターによりろ過滅菌する。
(Formulation 7: Injection)
Compound of the present invention 0.1-1 part Peanut oil After balance preparation, filter sterilize with a sterilization filter.
(製剤8:ポアオン剤)
 本発明化合物        5部
 ミリスチン酸エステル   10部
 イソプロパノール     バランス
(Formulation 8: Pour-on agent)
Compound of the present invention 5 parts Myristic acid ester 10 parts Isopropanol Balance
(製剤9:スポットオン剤)
 本発明化合物       10~15部
 パルミチン酸エステル   10部
 イソプロパノール     バランス
(Formulation 9: Spot-on agent)
Compound of the present invention 10-15 parts Palmitic acid ester 10 parts Isopropanol Balance
(製剤10:スプレーオン剤)
 本発明化合物        1部
 プロピレングリコール   10部
 イソプロパノール     バランス
(Formulation 10: Spray-on agent)
Compound of the present invention 1 part Propylene glycol 10 parts Isopropanol Balance
 次に、実施例を示し、本発明をより具体的に説明する。ただし、本発明は以下の実施例によって何ら制限されるものではない。 Next, the present invention will be described more specifically by showing examples. However, the present invention is not limited by the following examples.
〔実施例1〕 6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシム(化合物番号1-1)の合成
(工程1) 4-クロロ-6-(3,3-ジメチルブトキシ)ピリミジンの合成
Example 1 of 6- (3,3-Dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime (Compound No. 1-1) Synthesis (Step 1) Synthesis of 4-chloro-6- (3,3-dimethylbutoxy) pyrimidine
Figure JPOXMLDOC01-appb-C000010
Figure JPOXMLDOC01-appb-C000010
 55質量%水素化ナトリウム2.0g(45.7mmol)をテトラヒドロフラン70mlに懸濁させた。前記懸濁液に、氷冷下にて、3,3-ジメチルブタノール3.78g(37.0mmol)を滴下し、室温で15分間攪拌した。これに4,6-ジクロロピリミジン5.0g(33.6mmol)のテトラヒドロフラン溶液8mlを滴下した。その後、室温で4時間攪拌した。これに飽和塩化アンモニウム水溶液を加え、酢酸エチルにて抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮して、4-クロロ-6-(3,3-ジメチルブトキシ)ピリミジン7.21g(33.6mmol、収率100%)を得た。得られた4-クロロ-6-(3,3-ジメチルブトキシ)ピリミジンの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.55 (1H, s), 6.72 (1H, s), 4.42 (2H, t), 1.68 (2H, t), 0.96 (9H, s). 55 g of sodium hydride (2.0 g, 45.7 mmol) was suspended in 70 ml of tetrahydrofuran. Under cooling with ice, 3.78 g (37.0 mmol) of 3,3-dimethylbutanol was added dropwise to the suspension, followed by stirring at room temperature for 15 minutes. To this was added dropwise 8 ml of a tetrahydrofuran solution of 5.0 g (33.6 mmol) of 4,6-dichloropyrimidine. Then, it stirred at room temperature for 4 hours. A saturated aqueous ammonium chloride solution was added thereto, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure to give 7.21 g (33.6 mmol, 100% yield) of 4-chloro-6- (3,3-dimethylbutoxy) pyrimidine. 1 H-NMR data (CDCl 3 / TMSδ (ppm)) of the obtained 4-chloro-6- (3,3-dimethylbutoxy) pyrimidine: 8.55 (1H, s), 6.72 (1H, s), 4.42 ( 2H, t), 1.68 (2H, t), 0.96 (9H, s).
(工程2) 6-(3,3-ジメチルブトキシ)ピリミジン-4-カルボニトリルの合成 (Step 2) Synthesis of 6- (3,3-dimethylbutoxy) pyrimidine-4-carbonitrile
Figure JPOXMLDOC01-appb-C000011
Figure JPOXMLDOC01-appb-C000011
 4-クロロ-6-(3,3-ジメチルブトキシ)ピリミジン1.0g(4.66mmol)を57%ヨウ化水素水溶液10mlに加え、室温で一晩攪拌した。これに水10mlを加え、炭酸カリウムでpHを7に調製した。その後、クロロホルムにて抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮した。得られた残渣である4-(3,3-ジメチルブトキシ)-6-ヨードピリミジンと、ピリジン10mlおよびシアン化銅0.39g(4.66mmol)とを混合し、一晩加熱還流した。これを減圧下にて濃縮した。これに水を加え、酢酸エチルにて抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーにより精製し、6-(3,3-ジメチルブトキシ)ピリミジン-4-カルボニトリル0.53g(2.58mmol、収率55%)を得た。得られた6-(3,3-ジメチルブトキシ)ピリミジン-4-カルボニトリルの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.81 (1H, d), 7.03 (1H, d), 4.47 (2H, t), 1.70 (2H, t), 0.97 (9H, s). 1.0 g (4.66 mmol) of 4-chloro-6- (3,3-dimethylbutoxy) pyrimidine was added to 10 ml of a 57% aqueous hydrogen iodide solution, and the mixture was stirred overnight at room temperature. 10 ml of water was added thereto, and the pH was adjusted to 7 with potassium carbonate. Then, it extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure. The resulting residue, 4- (3,3-dimethylbutoxy) -6-iodopyrimidine, 10 ml of pyridine and 0.39 g (4.66 mmol) of copper cyanide were mixed and heated to reflux overnight. This was concentrated under reduced pressure. Water was added thereto, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain 0.53 g (2.58 mmol, yield 55%) of 6- (3,3-dimethylbutoxy) pyrimidine-4-carbonitrile. 1 H-NMR data (CDCl 3 / TMSδ (ppm)) of the obtained 6- (3,3-dimethylbutoxy) pyrimidine-4-carbonitrile: 8.81 (1H, d), 7.03 (1H, d), 4.47 (2H, t), 1.70 (2H, t), 0.97 (9H, s).
(工程3) 6-(3,3-ジメチルブトキシ)-N’-ヒドロキシピリミジン-4-カルボキシイミダミドの合成 (Step 3) Synthesis of 6- (3,3-dimethylbutoxy) -N′-hydroxypyrimidine-4-carboxyimidamide
Figure JPOXMLDOC01-appb-C000012
Figure JPOXMLDOC01-appb-C000012
 6-(3,3-ジメチルブトキシ)ピリミジン-4-カルボニトリル0.53g(2.58mmol)をメタノール(6ml)に溶解させた。この溶液にヒドロキシルアミン塩酸塩0.23g(3.35mmol)および炭酸カリウム0.45g(3.23mmol)を加え、3時間加熱還流した。これを減圧下で濃縮した。これに水を加え、酢酸エチルにて抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮して6-(3,3-ジメチルブトキシ)-N’-ヒドロキシピリミジン-4-カルボキシイミダミド0.54g(2.27mmol収率88%)を得た。得られた6-(3,3-ジメチルブトキシ)-N’-ヒドロキシピリミジン-4-カルボキシイミダミドの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.72 (1H, d), 7.19 (1H, d), 4.41 (2H, t), 1.70 (2H, t), 0.97 (9H, s). 0.53 g (2.58 mmol) of 6- (3,3-dimethylbutoxy) pyrimidine-4-carbonitrile was dissolved in methanol (6 ml). To this solution, 0.23 g (3.35 mmol) of hydroxylamine hydrochloride and 0.45 g (3.23 mmol) of potassium carbonate were added and heated to reflux for 3 hours. This was concentrated under reduced pressure. Water was added thereto, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure to give 0.54 g (2.27 mmol yield 88%) of 6- (3,3-dimethylbutoxy) -N′-hydroxypyrimidine-4-carboxyimidamide. 1 H-NMR data (CDCl 3 / TMSδ (ppm)) of the obtained 6- (3,3-dimethylbutoxy) -N′-hydroxypyrimidine-4-carboxyimidamide: 8.72 (1H, d), 7.19 ( 1H, d), 4.41 (2H, t), 1.70 (2H, t), 0.97 (9H, s).
(工程4) 6-(3,3-ジメチルブトキシ)-N’-エトキシピリミジン-4-カルビミドイルクロライドの合成 (Step 4) Synthesis of 6- (3,3-dimethylbutoxy) -N′-ethoxypyrimidine-4-carbimidoyl chloride
Figure JPOXMLDOC01-appb-C000013
Figure JPOXMLDOC01-appb-C000013
 55質量%水素化ナトリウム0.073g(1.68mmol)をN,N-ジメチルホルムアミド3mlに懸濁させた。前記懸濁液に、氷冷下にて、6-(3,3-ジメチルブトキシ)-N’-ヒドロキシピリミジン-4-カルボキシイミダミド0.40g(1.68mmol)のN,N-ジメチルホルムアミド溶液6mlを滴下した。その後、室温で30分間攪拌した。次いで、これに氷冷下にてヨウ化エチル0.29g(1.85mmol)を滴下した。その後、室温で2時間攪拌した。これに水を加え、次いで酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥させ、無機物を濾過で除去した。ろ液を減圧下に濃縮した。得られた6-(3,3-ジメチルブトキシ)-N’-エトキシピリミジン-4-カルボキシイミダミドと、酢酸3mlおよび濃塩酸6mlとを混合した。前記混合液に、-15℃にて、亜硝酸ナトリウム0.23g(3.36mmol)の水溶液を滴下した。その後、室温で4時間攪拌した。これに酢酸エチルを加え、水酸化ナトリウム水溶液で中和した。その後、酢酸エチルにて抽出した。有機層を無水硫酸マグネシウムで乾燥させ、無機物を濾過で除去した。ろ液を減圧下に濃縮して6-(3,3-ジメチルブトキシ)-N’-エトキシピリミジン-4-カルビミドイルクロライド0.40g(1.40mmol、収率83%)を得た。得られた6-(3,3-ジメチルブトキシ)-N’-エトキシピリミジン-4-カルビミドイルクロライドの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.82 (1H, s), 7.20 (1H, s), 4.46-4.39 (4H, m), 1.75-1.65 (2H, m), 1.45-1.35 (3H, m), 0.98 (9H, s). 0.073 g (1.68 mmol) of 55 mass% sodium hydride was suspended in 3 ml of N, N-dimethylformamide. A solution of 0.40 g (1.68 mmol) of 6- (3,3-dimethylbutoxy) -N′-hydroxypyrimidine-4-carboxyimidamide in N, N-dimethylformamide was added to the suspension under ice cooling. 6 ml was added dropwise. Then, it stirred at room temperature for 30 minutes. Next, 0.29 g (1.85 mmol) of ethyl iodide was added dropwise thereto under ice cooling. Then, it stirred at room temperature for 2 hours. Water was added to this and then extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and the inorganic material was removed by filtration. The filtrate was concentrated under reduced pressure. The obtained 6- (3,3-dimethylbutoxy) -N′-ethoxypyrimidine-4-carboxyimidamide was mixed with 3 ml of acetic acid and 6 ml of concentrated hydrochloric acid. An aqueous solution of 0.23 g (3.36 mmol) of sodium nitrite was added dropwise to the mixture at −15 ° C. Then, it stirred at room temperature for 4 hours. Ethyl acetate was added thereto and neutralized with an aqueous sodium hydroxide solution. Then, it extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and the inorganic material was removed by filtration. The filtrate was concentrated under reduced pressure to obtain 0.40 g (1.40 mmol, 83% yield) of 6- (3,3-dimethylbutoxy) -N′-ethoxypyrimidine-4-carbimidoyl chloride. 1 H-NMR data (CDCl 3 / TMSδ (ppm)) of the obtained 6- (3,3-dimethylbutoxy) -N′-ethoxypyrimidine-4-carbimidoyl chloride: 8.82 (1H, s), 7.20 (1H, s), 4.46-4.39 (4H, m), 1.75-1.65 (2H, m), 1.45-1.35 (3H, m), 0.98 (9H, s).
(工程5) 6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシムの合成 (Step 5) Synthesis of 6- (3,3-dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime
Figure JPOXMLDOC01-appb-C000014
Figure JPOXMLDOC01-appb-C000014
 6-(3,3-ジメチルブトキシ)-N’-エトキシピリミジン-4-カルビミドイルクロライド0.40g(1.40mmol)のN,N-ジメチルホルムアミド溶液8mlに、1,2,4-トリアゾール0.15g(2.10mmol)および炭酸カリウム0.39g(2.80mmol)を加え、90℃に加熱し、一晩攪拌した。得られた混合物に室温下にて水を加え、次いで酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーにより精製して6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシム0.22g(0.69mmol、収率49%)を得た。得られた6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.86 (1H, d), 8.80 (1H, d), 8.10 (1H, t), 7.03 (1H, s), 4.49-4.39 (4H, m), 1.74-1.70 (2H, m), 1.42-1.35 (3H, m), 0.99 (9H, s). To 8 ml of an N, N-dimethylformamide solution of 0.40 g (1.40 mmol) of 6- (3,3-dimethylbutoxy) -N′-ethoxypyrimidine-4-carbimidoyl chloride was added 1,2,4-triazole 0. .15 g (2.10 mmol) and 0.39 g (2.80 mmol) of potassium carbonate were added, heated to 90 ° C. and stirred overnight. Water was added to the resulting mixture at room temperature, followed by extraction with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give 6- (3,3-dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime. 0.22 g (0.69 mmol, 49% yield) was obtained. 1 H-NMR data of the obtained 6- (3,3-dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime (CDCl 3 / TMSδ (ppm)): 8.86 (1H, d), 8.80 (1H, d), 8.10 (1H, t), 7.03 (1H, s), 4.49-4.39 (4H, m), 1.74-1.70 (2H, m ), 1.42-1.35 (3H, m), 0.99 (9H, s).
〔実施例2〕
 前述の方法などに従って、6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-イソプロピルオキシム(化合物番号1-2)を製造した。得られた6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-イソプロピルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.87 (1H, s), 8.80 (1H, d), 8.08 (1H, s), 7.05 (1H, d), 4.69-4.61 (1H, m), 4.49-4.45 (2H, m), 1.75-1.71 (2H, m), 1.38-1.33 (6H, dd), 1.00 (9H, s).
[Example 2]
6- (3,3-Dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-isopropyloxime (compound number 1-2) Manufactured. 1 H-NMR data of the obtained 6- (3,3-dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-isopropyloxime (CDCl 3 / TMSδ (ppm)): 8.87 (1H, s), 8.80 (1H, d), 8.08 (1H, s), 7.05 (1H, d), 4.69-4.61 (1H, m), 4.49-4.45 (2H, m ), 1.75-1.71 (2H, m), 1.38-1.33 (6H, dd), 1.00 (9H, s).
〔実施例3〕
 前述の方法などに従って、6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-メチルオキシム(化合物番号1-3)を製造した。得られた6-(3,3-ジメチルブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-メチルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.82-8.81 (2H, m), 8.09 (1H, s), 7.03 (1H, d), 4.51-4.45 (2H, m), 4.16 (3H, s), 1.74-1.70 (2H, m), 0.99 (9H, s).
Example 3
6- (3,3-Dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-methyloxime (Compound No. 1-3) Manufactured. 1 H-NMR data of the obtained 6- (3,3-dimethylbutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-methyloxime (CDCl 3 / TMSδ (ppm)): 8.82-8.81 (2H, m), 8.09 (1H, s), 7.03 (1H, d), 4.51-4.45 (2H, m), 4.16 (3H, s), 1.74-1.70 (2H , m), 0.99 (9H, s).
〔実施例4〕 6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシム(化合物番号1-15)の合成
(工程1) 6-クロロ-N-エトキシピリミジン-4-カルボキサミドの合成
Example 4 6- (2,2,3,4,4,4-Hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyl Synthesis of oxime (Compound No. 1-15) (Step 1) Synthesis of 6-chloro-N-ethoxypyrimidine-4-carboxamide
Figure JPOXMLDOC01-appb-C000015
Figure JPOXMLDOC01-appb-C000015
 6-ヒドロキシピリミジン-4-カルボン酸1.00g(7.14mmol)に、塩化メチレン30ml、塩化オキサリル3.60g(28.4mmol)およびN,N-ジメチルホルムアミド0.05g(0.68mmol)を加え、3時間加熱還流した。反応液を減圧下で濃縮した。得られた残渣に塩化メチレン30mlを加え、氷冷下にて、O-エチルヒドロキシルアンモニウムクロリド0.70g(7.18mmol)およびトリエチルアミン1.45g(14.3mmol)を加え、室温で3時間攪拌した。反応液を減圧下で濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーにより精製して6-クロロ-N-エトキシピリミジン-4-カルボキサミド0.79g(3.92mmol、収率55%)を得た。得られた6-クロロ-N-エトキシピリミジン-4-カルボキサミドの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 10.08 (1H, s), 9.00 (1H, s), 8.13 (1H, s), 4.11 (2H, q), 1.35 (3H, t). To 1.00 g (7.14 mmol) of 6-hydroxypyrimidine-4-carboxylic acid was added 30 ml of methylene chloride, 3.60 g (28.4 mmol) of oxalyl chloride and 0.05 g (0.68 mmol) of N, N-dimethylformamide. Heated to reflux for 3 hours. The reaction was concentrated under reduced pressure. 30 ml of methylene chloride was added to the resulting residue, 0.70 g (7.18 mmol) of O-ethylhydroxylammonium chloride and 1.45 g (14.3 mmol) of triethylamine were added under ice cooling, and the mixture was stirred at room temperature for 3 hours. . The reaction was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain 0.79 g (3.92 mmol, 55% yield) of 6-chloro-N-ethoxypyrimidine-4-carboxamide. 1 H-NMR data (CDCl 3 / TMSδ (ppm)) of the obtained 6-chloro-N-ethoxypyrimidine-4-carboxamide: 10.08 (1H, s), 9.00 (1H, s), 8.13 (1H, s ), 4.11 (2H, q), 1.35 (3H, t).
(工程2) 6-クロロ-N-エトキシピリミジン-4-カルビミドイルクロライドの合成 (Step 2) Synthesis of 6-chloro-N-ethoxypyrimidine-4-carbimidoyl chloride
Figure JPOXMLDOC01-appb-C000016
Figure JPOXMLDOC01-appb-C000016
 6-クロロ-N-エトキシピリミジン-4-カルボキサミド1.00g(4.96mmol)のアセトニトリル溶液15mlに、トリフェニルホスフィン3.90g(14.9mmol)および四塩化炭素4.58g(29.8mmol)を加え、6時間加熱還流した。反応液を減圧下で濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーにより精製して6-クロロ-N-エトキシピリミジン-4-カルビミドイルクロライド0.71g(3.23mmol収率65%)を得た。得られた6-クロロ-N-エトキシピリミジン-4-カルビミドイルクロライドの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 9.06 (1H, s), 7.90 (1H, s), 4.45 (2H, q), 1.41 (3H, t).  To 15 ml of acetonitrile solution of 1.00 g (4.96 mmol) of 6-chloro-N-ethoxypyrimidine-4-carboxamide was added 3.90 g (14.9 mmol) of triphenylphosphine and 4.58 g (29.8 mmol) of carbon tetrachloride. In addition, the mixture was heated to reflux for 6 hours. The reaction was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain 0.71 g (3.23 mmol, 65% yield) of 6-chloro-N-ethoxypyrimidine-4-carbimidoyl chloride. 1 H-NMR data (CDCl 3 / TMSδ (ppm)) of the obtained 6-chloro-N-ethoxypyrimidine-4-carbimidoyl chloride: 9.06 (1H, s), 7.90 (1H, s), 4.45 ( 2H, q), 1.41 (3H, t).
(工程3) 6-(1H-1,2,4-トリアゾール-1-イル)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシムの合成 (Step 3) Synthesis of 6- (1H-1,2,4-triazol-1-yl) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime
Figure JPOXMLDOC01-appb-C000017
Figure JPOXMLDOC01-appb-C000017
 6-クロロ-N-エトキシピリミジン-4-カルビミドイルクロライド0.12g(0.55mmol)のN,N-ジメチルホルムアミド溶液3mlに、1,2,4-トリアゾール0.11g(1.59mmol)および炭酸カリウム0.22g(1.59mmol)を加え、110℃に加熱し、3時間攪拌した。得られた混合物に室温下にて水を加え、次いで酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーにより精製して6-(1H-1,2,4-トリアゾール-1-イル)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシム0.11g(0.39mmol、収率71%)を得た。得られた6-(1H-1,2,4-トリアゾール-1-イル)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 9.27 (1H, s), 9.09 (1H, s), 8.85 (1H, s), 8.25 (1H, s), 8.17 (1H, s), 8.11 (1H, s), 4.47 (2H, q), 1.41 (3H, t). To 3 ml of an N, N-dimethylformamide solution of 0.12 g (0.55 mmol) of 6-chloro-N-ethoxypyrimidine-4-carbimidoyl chloride, 0.11 g (1.59 mmol) of 1,2,4-triazole and Potassium carbonate 0.22g (1.59mmol) was added, and it heated at 110 degreeC, and stirred for 3 hours. Water was added to the resulting mixture at room temperature, followed by extraction with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give 6- (1H-1,2,4-triazol-1-yl) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) ) 0.11 g (0.39 mmol, 71% yield) of methanone-O-ethyloxime was obtained. The resulting 6- (1H-1,2,4- triazol-1-yl) pyrimidin-4-yl - (IH-1,2,4-triazol-1-yl) 1 H methanone -O- ethyl oxime -NMR data (CDCl 3 / TMSδ (ppm)): 9.27 (1H, s), 9.09 (1H, s), 8.85 (1H, s), 8.25 (1H, s), 8.17 (1H, s), 8.11 ( 1H, s), 4.47 (2H, q), 1.41 (3H, t).
(工程4) 6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシムの合成 (Step 4) 6- (2,2,3,4,4,4-Hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime Synthesis of
Figure JPOXMLDOC01-appb-C000018
Figure JPOXMLDOC01-appb-C000018
 6-(1H-1,2,4-トリアゾール-1-イル)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシム0.10g(0.35mmol)のN,N-ジメチルホルムアミド溶液2mlに、2,2,3,4,4,4-ヘキサフルオロブタノール0.09g(0.49mmol)および炭酸カリウム0.07g(0.51mmol)を加え、110℃に加熱し、6時間攪拌した。得られた混合物に室温下にて水を加え、次いで酢酸エチルで抽出した。有機層を無水硫酸マグネシウムで乾燥させ、次いで無機物を濾過で除去した。ろ液を減圧下で濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーにより精製して6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシム0.08g(0.20mmol、収率57%)を得た。得られた6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-エチルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.86 (1H, s), 8.85 (1H, s), 8.10 (1H, s), 7.24 (1H, s), 5.18-5.01 (1H, m), 4.88-4.81 (2H, m), 4.43 (2H, q), 1.40 (3H, t). 0.10 g (0. 1H-1,2,4-triazol-1-yl) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime 35 mmol) of N, N-dimethylformamide in 2 ml of 2,2,3,4,4,4-hexafluorobutanol 0.09 g (0.49 mmol) and potassium carbonate 0.07 g (0.51 mmol) were added, Heat to 110 ° C. and stir for 6 hours. Water was added to the resulting mixture at room temperature, followed by extraction with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and then the inorganics were removed by filtration. The filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give 6- (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazole-1 0.08 g (0.20 mmol, 57% yield) of -yl) methanone-O-ethyloxime was obtained. Of the obtained 6- (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-ethyloxime 1 H-NMR data (CDCl 3 / TMSδ (ppm)): 8.86 (1H, s), 8.85 (1H, s), 8.10 (1H, s), 7.24 (1H, s), 5.18-5.01 (1H, m ), 4.88-4.81 (2H, m), 4.43 (2H, q), 1.40 (3H, t).
〔実施例5〕
 前述の方法などに従って、6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-イソプロピルオキシム(化合物番号1-77)を製造した。得られた6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-イソプロピルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.87 (1H, s), 8.85 (1H, s), 8.09 (1H, s), 7.25 (1H, s), 5.19-5.01 (1H, m), 4.88-4.82 (2H, m), 4.69-4.62 (1H, m), 1.38 (6H, d).
Example 5
6- (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-- Isopropyl oxime (Compound No. 1-77) was prepared. Of the obtained 6- (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-isopropyloxime 1 H-NMR data (CDCl 3 / TMSδ (ppm)): 8.87 (1H, s), 8.85 (1H, s), 8.09 (1H, s), 7.25 (1H, s), 5.19-5.01 (1H, m ), 4.88-4.82 (2H, m), 4.69-4.62 (1H, m), 1.38 (6H, d).
〔実施例6〕
 前述の方法などに従って、6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-メチルオキシム(化合物番号1-75)を製造した。得られた6-(2,2,3,4,4,4-ヘキサフルオロブトキシ)ピリミジン-4-イル-(1H-1,2,4-トリアゾール-1-イル)メタノン-O-メチルオキシムの1H-NMRデータ (CDCl3/TMSδ (ppm)) : 8.85 (1H, s), 8.83 (1H, s), 8.10 (1H, s), 7.24 (1H, s), 5.18-5.00 (1H, m), 4.88-4.80 (2H, m), 4.18 (3H, s).
Example 6
6- (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-- Methyl oxime (Compound No. 1-75) was prepared. Of the resulting 6- (2,2,3,4,4,4-hexafluorobutoxy) pyrimidin-4-yl- (1H-1,2,4-triazol-1-yl) methanone-O-methyloxime 1 H-NMR data (CDCl 3 / TMSδ (ppm)): 8.85 (1H, s), 8.83 (1H, s), 8.10 (1H, s), 7.24 (1H, s), 5.18-5.00 (1H, m ), 4.88-4.80 (2H, m), 4.18 (3H, s).
 実施例と同様にして製造された本発明化合物を、実施例の化合物も含めて、以下の第1表および第2表に示す。
 第1表および第2表に記入されている略号は、次の意味を表す。
Et:エチル基、Pr:イソプロピル基、Me:メチル基、Bu:t-ブチル基、Ph:フェニル基、Hex:n-ヘキシル基、Pen:イソペンチル基、Py-3-yl:ピリジン-3-イル基、Pr:シクロプロピル基、Py-2-yl:ピリジン-2-イル基、Hex:シクロヘキシル基。
(X11)m1の欄が「-」:m1が0、(X)nの欄が「-」:nが0。
*1の欄の略号に関し、EはE異性体、ZはZ異性体、EZはE異性体とZ異性体の混合物を表す。
第2表に記入されている略号は、次の意味を表す。
A(3)は3を付した位置のAを表す。以下、A(4)は4を付した位置のAを、A(5)は5を付した位置のAを表す。
The compounds of the present invention produced in the same manner as in Examples, including the compounds of Examples, are shown in Tables 1 and 2 below.
The abbreviations entered in Tables 1 and 2 represent the following meanings.
Et: ethyl group, i Pr: isopropyl group, Me: methyl group, t Bu: t-butyl group, Ph: phenyl group, n Hex: n-hexyl group, i Pen: isopentyl group, Py-3-yl: pyridine -3-yl group, c Pr: cyclopropyl group, Py-2-yl: pyridin-2-yl group, c Hex: cyclohexyl group.
The column of (X 11 ) m1 is “-”: m1 is 0, and the column of (X 2 ) n is “-”: n is 0.
* Regarding the abbreviations in the column of * 1, E represents E isomer, Z represents Z isomer, and EZ represents a mixture of E isomer and Z isomer.
The abbreviations entered in Table 2 have the following meanings.
A (3) represents A at the position marked with 3. Hereinafter, A (4) represents A at a position marked with 4, and A (5) represents A at a position marked with 5.
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000023
 第3表に上記の第1表および第2表に記載した化合物の物性値を示す。「m.p.」は融点を表す。「nD」は屈折率を表す。
Figure JPOXMLDOC01-appb-T000024
Table 3 shows the physical property values of the compounds described in Tables 1 and 2 above. “Mp” represents the melting point. “ND” represents a refractive index.
Figure JPOXMLDOC01-appb-T000024
Figure JPOXMLDOC01-appb-T000025
Figure JPOXMLDOC01-appb-T000025
Figure JPOXMLDOC01-appb-T000026
Figure JPOXMLDOC01-appb-T000026
Figure JPOXMLDOC01-appb-T000027
Figure JPOXMLDOC01-appb-T000027
〔生物試験〕
 本発明化合物が、有害生物防除剤、特には殺虫剤の有効成分として有用であることを以下の試験例で示す。
[Biological test]
The following test examples show that the compounds of the present invention are useful as active ingredients for pest control agents, particularly insecticides.
(試験例1) マメアブラムシに対する効力試験
 先に、本発明化合物5部、ジメチルホルムアミド93.6部、およびポリオキシエチレンアルキルアリールエーテル1.4部を混合溶解し、有効成分5%の乳剤を調製した。
初生葉の展開したササゲにマメアブラムシ成虫を放した。放虫から1日経過した時に、産下された1齢幼虫を残し、成虫を除去した。続いて、前記の乳剤を化合物濃度125ppmになるように水で希釈し、この薬液を前記のササゲに散布した。
その後、ササゲを温度25℃、湿度60%の恒温室内に保持した。そして、散布から4日経過した時にマメアブラムシの生死を調べ、殺虫率を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も80%以上であった。
 1-1、1-3、1-5、1-6、1-7、1-8、1-9、1-10、1-11、1-12、1-13、1-15、1-16、1-17、1-18、1-19、1-20、1-21、1-22、1-26、1-27、1-30、1-31、1-32、1-33、1-35、1-36、1-37、1-38、1-39、1-40、1-41、1-46、1-47、1-48、1-49、1-50、1-51、1-54、1-58、1-62、1-65、1-66、1-68、1-69、1-71、1-72、1-74、1-75、1-76、1-77、1-78、1-79、1-81、1-82、1-83、1-86、1-87、1-88、1-90、1-91、1-92、1-93、1-94、1-95、1-96、1-97、1-98、1-99、1-100、1-101、1-104、1-110、および1-111。
Test Example 1 Efficacy Test for Bean Aphids First, 5 parts of the compound of the present invention, 93.6 parts of dimethylformamide and 1.4 parts of polyoxyethylene alkylaryl ether were mixed and dissolved to prepare an emulsion containing 5% active ingredient. did.
The bean aphid was released on the cowpea where the primary leaves developed. When 1 day had passed since the release, the 1st instar larvae were left and adults were removed. Subsequently, the emulsion was diluted with water to a compound concentration of 125 ppm, and this chemical solution was sprayed on the cowpea.
Thereafter, the cowpea was kept in a temperature-controlled room at a temperature of 25 ° C. and a humidity of 60%. When 4 days had passed since spraying, the aphids were examined for life and death, and the insecticidal rate was determined.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All the compounds were 80% or more.
1-1, 1-3, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1-13, 1-15, 1- 16, 1-17, 1-18, 1-19, 1-20, 1-21, 1-22, 1-26, 1-27, 1-30, 1-31, 1-32, 1-33, 1-35, 1-36, 1-37, 1-38, 1-39, 1-40, 1-41, 1-46, 1-47, 1-48, 1-49, 1-50, 1- 51, 1-54, 1-58, 1-62, 1-65, 1-66, 1-68, 1-69, 1-71, 1-72, 1-74, 1-75, 1-76, 1-77, 1-78, 1-79, 1-81, 1-82, 1-83, 1-86, 1-87, 1-88, 1-90, 1-91, 1-92, 1- 93, 1-94, 1-95, 1-96, 1-97, 1-98, 1-99, 1-100, 1-101, 1-104, 1-110, and 1-111.
(試験例2) トビイロウンカに対する効力試験
 試験例1に記載の乳剤を化合物濃度125ppmになるように水で希釈し、この薬液にイネ実生を10秒間浸漬して、次いで風乾させた。
穴をあけたビニール袋をイネ実生にかぶせた。トビイロウンカ2齢幼虫10頭をビニール袋の中で放した。該イネ実生を温度25℃、湿度60%の恒温室内に保持した。放虫から6日経過した時にトビイロウンカの生死を調べ、殺虫率を求めた。なお、トビイロウンカとして、(A)薬剤感受性系統と(B)薬剤低感受性系統(2011年に熊本県で採集し室内で飼育維持した系統)との2種を用いた。
(Test Example 2) Efficacy test against brown planthopper The emulsion described in Test Example 1 was diluted with water to a compound concentration of 125 ppm, rice seedlings were immersed in this chemical solution for 10 seconds, and then air-dried.
A plastic bag with holes was put on rice seedlings. Ten second instar larvae were released in plastic bags. The rice seedlings were kept in a thermostatic chamber at a temperature of 25 ° C. and a humidity of 60%. When 6 days had passed since the release of the insects, the survival of the brown planthopper was examined and the insecticidal rate was determined. As the brown planthopper, two types of (A) drug-sensitive lines and (B) drug-insensitive lines (lines collected in Kumamoto Prefecture in 2011 and kept indoors) were used.
 以下に示す化合物をそれぞれ含有する薬液について、(A)薬剤感受性系統を用いて試験を行った。いずれの化合物も殺虫率が80%以上であった。
 1-1、1-2、1-3、1-4、1-5、1-6、1-7、1-8、1-9、1-10、1-11、1-12、1-13、1-15、1-16、1-17、1-18、1-20、1-21、1-22、1-25、1-26、1-30、1-31、1-32、1-33、1-35、1-36、1-38、1-39、1-40、1-41、1-43、1-46、1-47、1-48、1-49、1-50、1-51、1-58、1-63、1-65、1-66、1-68、1-69、1-71、1-72、1-74、1-75、1-76、1-77、1-78、1-79、1-80、1-81、1-82、1-83、1-86、1-87、1-90、1-93、1-94、1-95、1-96、1-97、1-98、1-99、1-100、1-101、1-107、1-110、1-111、および1-121。
About the chemical | medical solution which respectively contains the compound shown below, it tested using the (A) drug sensitivity system | strain. All compounds had an insecticidal rate of 80% or more.
1-1, 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1- 13, 1-15, 1-16, 1-17, 1-18, 1-20, 1-21, 1-22, 1-25, 1-26, 1-30, 1-31, 1-32, 1-33, 1-35, 1-36, 1-38, 1-39, 1-40, 1-41, 1-43, 1-46, 1-47, 1-48, 1-49, 1- 50, 1-51, 1-58, 1-63, 1-65, 1-66, 1-68, 1-69, 1-71, 1-72, 1-74, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-81, 1-82, 1-83, 1-86, 1-87, 1-90, 1-93, 1-94, 1- 95, 1-96, 1-97, 1-98, 1-99, 1-100, 1-101, 1-107, 1-110, 1-111, and 1-121.
 同様の手法で、化合物濃度8ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
 1-1、1-2、1-5、1-7、1-8、1-10、1-13、1-15、1-18、1-20、1-22、1-25、1-32、1-33、1-39、1-46、1-47、1-51、1-66、1-68、1-69、1-71、1-72、1-76、1-78、1-80、1-81、1-83、1-86、1-93、1-94、1-111、および1-121。
同様の手法で、化合物濃度2ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
 1-4、1-21、1-26、1-35、1-36、1-65、および1-77。
In the same manner, the efficacy test was conducted at a compound concentration of 8 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-1, 1-2, 1-5, 1-7, 1-8, 1-10, 1-13, 1-15, 1-18, 1-20, 1-22, 1-25, 1- 32, 1-33, 1-39, 1-46, 1-47, 1-51, 1-66, 1-68, 1-69, 1-71, 1-72, 1-76, 1-78, 1-80, 1-81, 1-83, 1-86, 1-93, 1-94, 1-111, and 1-121.
In the same manner, the efficacy test was conducted at a compound concentration of 2 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-4, 1-21, 1-26, 1-35, 1-36, 1-65, and 1-77.
 以下に示す化合物をそれぞれ含有する薬液について、(B)薬剤低感受性系統を用いて試験を行った。いずれの化合物も殺虫率が80%以上であった。
 1-1、1-2、1-3、1-4、1-5、1-15、1-21、1-26、1-36、1-38、1-39、1-40、1-46、1-47、1-65、1-66、1-69、1-77、1-78、1-79、1-80、1-86、1-94、および1-95。
About the chemical | medical solution which respectively contains the compound shown below, it tested using the (B) chemical | medical agent low sensitivity system | strain. All compounds had an insecticidal rate of 80% or more.
1-1, 1-2, 1-3, 1-4, 1-5, 1-15, 1-21, 1-26, 1-36, 1-38, 1-39, 1-40, 1- 46, 1-47, 1-65, 1-66, 1-69, 1-77, 1-78, 1-79, 1-80, 1-86, 1-94, and 1-95.
 同様の手法で、化合物濃度31ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
 1-2、1-4、1-5、1-15、1-26、1-46、1-47、1-69、1-80、1-86、および1-94。
同様の手法で、化合物濃度8ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
1-1、1-21、1-66、1-77、および1-78。
In the same manner, the efficacy test was conducted at a compound concentration of 31 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-2, 1-4, 1-5, 1-15, 1-26, 1-46, 1-47, 1-69, 1-80, 1-86, and 1-94.
In the same manner, the efficacy test was conducted at a compound concentration of 8 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-1, 1-21, 1-66, 1-77, and 1-78.
 イミダクロプリドは、(A)薬剤感受性系統に対して、125ppmで100%の殺虫率を示した。(B)薬剤低感受性系統に対しては、50%の殺虫率であった。 Imidacloprid showed an insecticidal rate of 100% at 125 ppm with respect to (A) drug-sensitive line. (B) The insecticidal rate was 50% for the drug-insensitive line.
 ブプロフェジンは、(A)薬剤感受性系統に対して、125ppmで100%の殺虫率を示した。(B)薬剤低感受性系統に対しては、70%の殺虫率であった。 Buprofezin showed a 100% insecticidal rate at 125 ppm with respect to (A) drug-sensitive line. (B) The insecticidal rate was 70% for the drug-insensitive line.
特許文献2に記載の以下に示す(化合物No.26)は、(A)薬剤感受性系統に対して、31ppmで80%以上の殺虫率を示したが、8ppmでは80%以上の殺虫率を示さなかった。 (Compound No. 26) shown below in Patent Document 2 showed an insecticidal rate of 80% or more at 31 ppm with respect to (A) drug-sensitive strain, but showed an insecticidal rate of 80% or more at 8 ppm. There wasn't.
Figure JPOXMLDOC01-appb-C000028
Figure JPOXMLDOC01-appb-C000028
(試験例3) ワタアブラムシに対する効力試験
 3寸鉢に播種し発芽後10日経過したキュウリに、ワタアブラムシ成虫を放した。放虫から1日経過した時に、産下された1齢幼虫を残し、成虫を除去した。試験例1に記載の乳剤を、化合物濃度が125ppmになるように水で希釈し、この薬液を前記のキュウリに散布した。
その後、キュウリを温度25℃、湿度60%の恒温室内に保持した。散布から5日経過した時にワタアブラムシの生死を調べ、殺虫率を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も殺虫率が80%以上であった。
 1-1、1-2、1-3、1-4、1-5、1-6、1-7、1-8、1-9、1-10、1-11、1-12、1-13、1-15、1-16、1-17、1-18、1-19、1-20、1-21、1-22、1-25、1-26、1-30、1-31、1-32、1-33、1-35、1-36、1-37、1-38、1-39、1-40、1-41、1-46、1-47、1-48、1-49、1-50、1-51、1-58、1-63、1-65、1-66、1-69、1-71、1-72、1-75、1-76、1-77、1-78、1-79、1-80、1-82、1-83、1-86、1-87、1-88、1-90、1-91、1-92、1-93、1-94、1-95、1-96、1-97、1-98、1-99、1-100、1-101、1-104、1-106、1-107、1-110、1-111、および1-121。
(Test Example 3) Efficacy test against cotton aphids Adult cotton aphids were released on cucumbers that had been sown in 3-inch pots and 10 days after germination. When 1 day had passed since the release, the 1st instar larvae were left and adults were removed. The emulsion described in Test Example 1 was diluted with water so that the compound concentration was 125 ppm, and this chemical solution was sprayed onto the cucumber.
Thereafter, the cucumber was kept in a constant temperature room at a temperature of 25 ° C. and a humidity of 60%. After 5 days from spraying, the aphids were examined for life and death, and the insecticidal rate was determined.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All compounds had an insecticidal rate of 80% or more.
1-1, 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1- 13, 1-15, 1-16, 1-17, 1-18, 1-19, 1-20, 1-21, 1-22, 1-25, 1-26, 1-30, 1-31, 1-32, 1-33, 1-35, 1-36, 1-37, 1-38, 1-39, 1-40, 1-41, 1-46, 1-47, 1-48, 1- 49, 1-50, 1-51, 1-58, 1-63, 1-65, 1-66, 1-69, 1-71, 1-72, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-82, 1-83, 1-86, 1-87, 1-88, 1-90, 1-91, 1-92, 1-93, 1- 94, 1-95, 1-96, 1-97, 1-98, 1-99, 1-100, 1-101, 1-104, 1-106, 1-107, 1-110, 1-111, And 1-121.
 同様の手法で、化合物濃度31ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
 1-2、1-3、1-4、1-5、1-13、1-16、1-19、1-30、1-32、1-33、1-37、1-46、1-47、1-48、1-49、1-50、1-51、1-63、1-69、1-86、1-87、1-88、1-94、1-95、1-96、1-97、1-98、1-99、1-101、および1-110。
同様の手法で、化合物濃度8ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
1-1、1-7、1-10、1-12、1-15、1-17、1-18、1-20、1-21、1-22、1-26、1-31、1-35、1-36、1-38、1-39、1-40、1-58、1-65、1-66、1-75、1-76、1-77、1-78、1-79、1-80、1-93、1-100、1-104、1-111、および1-121。
In the same manner, the efficacy test was conducted at a compound concentration of 31 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-2, 1-3, 1-4, 1-5, 1-13, 1-16, 1-19, 1-30, 1-32, 1-33, 1-37, 1-46, 1- 47, 1-48, 1-49, 1-50, 1-51, 1-63, 1-69, 1-86, 1-87, 1-88, 1-94, 1-95, 1-96, 1-97, 1-98, 1-99, 1-101, and 1-110.
In the same manner, the efficacy test was conducted at a compound concentration of 8 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-1, 1-7, 1-10, 1-12, 1-15, 1-17, 1-18, 1-20, 1-21, 1-22, 1-26, 1-31, 1- 35, 1-36, 1-38, 1-39, 1-40, 1-58, 1-65, 1-66, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-93, 1-100, 1-104, 1-111, and 1-121.
なお、特許文献2に記載(化合物No.26)は、125ppmで80%以上の殺虫率を示したが、31ppmでは80%以上の殺虫率を示さなかった。 In addition, although description (compound No. 26) described in patent document 2 showed an insecticidal rate of 80% or more at 125 ppm, it did not show an insecticidal rate of 80% or more at 31 ppm.
(試験例4) モモアカアブラムシに対する効力試験
 ハツカダイコン幼苗にモモアカアブラムシ成虫を放した。放虫から1日経過した時に、産下された1齢幼虫を残し、成虫を除去した。試験例1に記載の乳剤を、化合物濃度が125ppmになるように水で希釈し、この薬液に、前記ハツカダイコンを10秒間浸漬した。
その後、ハツカダイコンを温度25℃、湿度60%の恒温室内に保持した。浸漬から6日経過した時にモモアカアブラムシの生死を調べ、殺虫率を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も殺虫率が80%以上であった。
 1-1、1-2、1-3、1-5、1-6、1-10、1-12、1-13、1-15、1-17、1-18、1-20、1-21、1-22、1-26、1-31、1-36、1-37、1-38、1-39、1-40、1-46、1-47、1-48、1-49、1-51、1-58、1-65、1-66、1-69、1-75、1-76、1-77、1-78、1-79、1-80、1-82、1-86、1-93、1-94、1-96、1-97、1-98、1-99、1-100、1-101、1-104、1-111、および1-121。
(Test Example 4) Efficacy test against peach aphid Adult peach aphid was released on a Japanese radish seedling. When 1 day had passed since the release, the 1st instar larvae were left and adults were removed. The emulsion described in Test Example 1 was diluted with water so that the compound concentration was 125 ppm, and the radish was immersed in this chemical solution for 10 seconds.
Thereafter, the radish was kept in a temperature-controlled room at a temperature of 25 ° C. and a humidity of 60%. When 6 days have passed since the immersion, the mortality of the peach aphid was examined to determine the insecticidal rate.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All compounds had an insecticidal rate of 80% or more.
1-1, 1-2, 1-3, 1-5, 1-6, 1-10, 1-12, 1-13, 1-15, 1-17, 1-18, 1-20, 1- 21, 1-22, 1-26, 1-31, 1-36, 1-37, 1-38, 1-39, 1-40, 1-46, 1-47, 1-48, 1-49, 1-51, 1-58, 1-65, 1-66, 1-69, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-82, 1- 86, 1-93, 1-94, 1-96, 1-97, 1-98, 1-99, 1-100, 1-101, 1-104, 1-111, and 1-121.
 同様の手法で、化合物濃度31ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
 1-3、1-10、1-15、1-20、1-21、1-26、1-31、1-46、1-47、1-48、1-58、1-65、1-66、1-69、1-75、1-76、1-77、1-78、1-79、1-80、1-94、1-96、1-97、1-98、1-99、1-104、1-111、および1-121。
In the same manner, the efficacy test was conducted at a compound concentration of 31 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-3, 1-10, 1-15, 1-20, 1-21, 1-26, 1-31, 1-46, 1-47, 1-48, 1-58, 1-65, 1- 66, 1-69, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-94, 1-96, 1-97, 1-98, 1-99, 1-104, 1-111, and 1-121.
なお、特許文献2に記載の(化合物No.26)は、125ppmで80%以上の殺虫率を示さなかった。 In addition, (Compound No. 26) described in Patent Document 2 did not show an insecticidal rate of 80% or more at 125 ppm.
(試験例5) ツマグロヨコバイに対する効力試験
 試験例1に記載の乳剤を化合物濃度が125ppmになるように水で希釈し、この薬液にイネ実生を10秒間浸漬し、風乾させた。
穴をあけたビニール袋を前記イネ実生にかぶせた。ビニール袋内にツマグロヨコバイ2齢幼虫を10頭放した。イネ実生を温度25℃、湿度60%の恒温室内に保持した。放虫から6日経過した時にツマグロヨコバイの生死を調べ、殺虫率を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も殺虫率が80%以上であった。
 1-1、1-2、1-3、1-4、1-5、1-6、1-7、1-8、1-10、1-11、1-12、1-15、1-16、1-17、1-18、1-20、1-21、1-22、1-26、1-27、1-30、1-31、1-32、1-33、1-35、1-36、1-38、1-39、1-40、1-41、1-43、1-46、1-47、1-48、1-49、1-50、1-51、1-54、1-58、1-63、1-65、1-66、1-68、1-69、1-71、1-72、1-74、1-75、1-76、1-77、1-78、1-80、1-81、1-83、1-86、1-88、1-90、1-91、1-93、1-95、1-97、1-98、1-99、1-100、1-101、1-110、および1-111。
(Test Example 5) Efficacy test against leafhopper leaf The emulsion described in Test Example 1 was diluted with water to a compound concentration of 125 ppm, and rice seedlings were immersed in this chemical solution for 10 seconds and allowed to air dry.
A plastic bag with a hole was put on the rice seedlings. Ten second instar larvae were released in a plastic bag. Rice seedlings were kept in a constant temperature room at a temperature of 25 ° C. and a humidity of 60%. When 6 days had passed since the release, the viability of the leafhopper was examined and the insecticidal rate was determined.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All compounds had an insecticidal rate of 80% or more.
1-1, 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-10, 1-11, 1-12, 1-15, 1- 16, 1-17, 1-18, 1-20, 1-21, 1-22, 1-26, 1-27, 1-30, 1-31, 1-32, 1-33, 1-35, 1-36, 1-38, 1-39, 1-40, 1-41, 1-43, 1-46, 1-47, 1-48, 1-49, 1-50, 1-51, 1- 54, 1-58, 1-63, 1-65, 1-66, 1-68, 1-69, 1-71, 1-72, 1-74, 1-75, 1-76, 1-77, 1-78, 1-80, 1-81, 1-83, 1-86, 1-88, 1-90, 1-91, 1-93, 1-95, 1-97, 1-98, 1- 99, 1-100, 1-101, 1-110, and 1-111.
 同様の手法で、化合物濃度31ppmにて効力試験を行った。以下に示す化合物は、80%以上の殺虫率を示した。
1-1、1-2、1-3、1-4、1-5、1-10、1-11、1-12、1-15、1-16、1-17、1-18、1-20、1-21、1-22、1-26、1-27、1-30、1-31、1-32、1-33、1-35、1-36、1-38、1-39、1-40、1-46、1-47、1-48、1-49、1-50、1-51、1-54、1-58、1-63、1-65、1-66、1-68、1-69、1-71、1-72、1-74、1-75、1-76、1-77、1-78、1-80、1-86、1-90、1-91、1-93、1-95、1-97、1-98、1-99、1-100、および1-111。
In the same manner, the efficacy test was conducted at a compound concentration of 31 ppm. The compounds shown below showed an insecticidal rate of 80% or more.
1-1, 1-2, 1-3, 1-4, 1-5, 1-10, 1-11, 1-12, 1-15, 1-16, 1-17, 1-18, 1- 20, 1-21, 1-22, 1-26, 1-27, 1-30, 1-31, 1-32, 1-33, 1-35, 1-36, 1-38, 1-39, 1-40, 1-46, 1-47, 1-48, 1-49, 1-50, 1-51, 1-54, 1-58, 1-63, 1-65, 1-66, 1- 68, 1-69, 1-71, 1-72, 1-74, 1-75, 1-76, 1-77, 1-78, 1-80, 1-86, 1-90, 1-91, 1-93, 1-95, 1-97, 1-98, 1-99, 1-100, and 1-111.
なお、特許文献2に記載の(化合物No.26)は、125ppmで80%以上の殺虫率を示さなかった。 In addition, (Compound No. 26) described in Patent Document 2 did not show an insecticidal rate of 80% or more at 125 ppm.
(試験例6) タバココナジラミに対する効力試験
 試験例1に記載の乳剤を本発明化合物濃度が125ppmになるように水で希釈し、この試験薬液をトマト切り取り葉に散布し、次いで風乾した。
フラスコ内で、脱脂綿を用いて、葉表が上方に向くように葉を固定した。このフラスコ内にタバココナジラミtypeB成虫7ペアを放虫して、トマト切り取り葉に寄生させ、温度25℃、湿度60%の恒温室内に保持した。放虫から2日経過時に成虫の生死を調べ、殺虫率を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も殺虫率が80%以上であった。
 1-5、1-10、1-11、1-15、1-20、1-21、1-22、1-26、1-31、1-32、1-33、1-35、1-36、1-37、1-38、1-39、1-40、1-46、1-51、1-65、1-66、1-68、1-69、1-71、1-72、1-74、1-75、1-76、1-77、1-78、1-79、1-80、1-83、1-88、1-94、および1-100。
(Test Example 6) Efficacy test against tobacco whitefly The emulsion described in Test Example 1 was diluted with water so that the concentration of the compound of the present invention was 125 ppm, and this test chemical solution was sprayed on tomato cut leaves and then air-dried.
In the flask, the leaf was fixed using absorbent cotton so that the leaf surface faced upward. In this flask, 7 pairs of adult whitefly whitefly type B were released, infested with tomato cut leaves, and kept in a thermostatic chamber at a temperature of 25 ° C. and a humidity of 60%. When two days had passed since the release, adults were examined for viability and the insecticidal rate was determined.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All compounds had an insecticidal rate of 80% or more.
1-5, 1-10, 1-11, 1-15, 1-20, 1-21, 1-22, 1-26, 1-31, 1-32, 1-33, 1-35, 1- 36, 1-37, 1-38, 1-39, 1-40, 1-46, 1-51, 1-65, 1-66, 1-68, 1-69, 1-71, 1-72, 1-74, 1-75, 1-76, 1-77, 1-78, 1-79, 1-80, 1-83, 1-88, 1-94, and 1-100.
(試験例7) リンゴ黒星病防除試験
 先に、1.5%のポリオキシエチレンソルビタンモノラウレートを含有するジメチルホルムアミド95部と、本発明化合物5部を混合溶解し、有効成分5%の乳剤を調製した。
前記の乳剤を化合物濃度が100ppmになるように、0.01%のポリオキシエチレンソルビタンモノラウレートを含有する水で希釈し、この薬液を素焼きポットで栽培したリンゴ幼苗(品種「国光」、3~4葉期)に散布した。
葉を風乾させた後、リンゴ黒星病菌(Venturia inaequalis)の分生胞子をリンゴ幼苗に接種し、該リンゴ幼苗を、明暗を12時間毎に繰り返す20℃、高湿度の恒温室内で2週間保持した。葉上の病斑出現状態を無処理と比較調査し防除価を求めた。
 化合物番号1-2の化合物を含有する薬液について、前記試験を行った。本化合物は、75%以上の防除価を示した。
(Test Example 7) Apple scab control test First, 95 parts of dimethylformamide containing 1.5% of polyoxyethylene sorbitan monolaurate and 5 parts of the compound of the present invention were mixed and dissolved to give an emulsion containing 5% of active ingredient. Was prepared.
The above-mentioned emulsion was diluted with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration was 100 ppm, and this seedling was cultivated in an unglazed pot (apple variety “Kokumi”, 3 (4th leaf stage).
After the leaves were air-dried, apple seedlings of Venturia inaequalis were inoculated into apple seedlings, and the apple seedlings were kept in a temperature-controlled room at 20 ° C. and high humidity for 2 weeks. . The lesion appearance on the leaves was compared with no treatment to determine the control value.
The test was conducted on a chemical solution containing the compound No. 1-2. This compound exhibited a control value of 75% or more.
(試験例8) コムギうどんこ病防除試験
試験例7に記載の乳剤を化合物濃度が100ppmになるように、0.01%のポリオキシエチレンソルビタンモノラウレートを含有する水で希釈し、この薬液を、素焼きポットで栽培したコムギ幼苗(品種「チホク」、1.0~1.2葉期)に散布した。
葉を風乾させた後、コムギうどんこ病菌(Erysiphe graminis f.sp.tritici)の分生胞子を振り払い接種し、該コムギ幼苗を、22~25℃の温室で7日間保持した。葉上の病斑出現状態を無処理と比較調査し、防除効果を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も防除価が75%以上であった。
1-1、1-6、1-10、1-13、1-15、1-18、1-21、1-32、1-33、1-36、1-39、1-40、1-66、1-69、1-71、1-72、1-74、1-76、1-87、1-93、1-100、2-1、および2-2。
(Test Example 8) The emulsion described in Test Example 7 for wheat powdery mildew control was diluted with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration would be 100 ppm. Was sprayed on wheat seedlings grown in an unglazed pot (variety “Chihoku”, 1.0-1.2 leaf stage).
After the leaves were air-dried, conidia of wheat powdery mildew (Erysiphe graminis f. Sp. Tritici) were sprinkled and inoculated, and the wheat seedlings were kept in a 22-25 ° C. greenhouse for 7 days. The lesion appearance state on the leaf was compared with no treatment, and the control effect was obtained.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All the compounds had a control value of 75% or more.
1-1, 1-6, 1-10, 1-13, 1-15, 1-18, 1-21, 1-32, 1-33, 1-36, 1-39, 1-40, 1- 66, 1-69, 1-71, 1-72, 1-74, 1-76, 1-87, 1-93, 1-100, 2-1, and 2-2.
(試験例9) コムギ赤さび病防除試験
 試験例7に記載の乳剤を化合物濃度が100ppmになるように、0.01%のポリオキシエチレンソルビタンモノラウレートを含有する水で希釈して、薬液を調製した。 続いて、薬液を、素焼きポットで栽培したコムギ幼苗(品種「農林61号」、1.0~1.2葉期)に散布した。
葉を風乾させた後、コムギ赤さび病菌(Puccinia recondita)の夏胞子を振り払い接種し、コムギ幼苗を、22~25℃の温室で10日間保持した。葉上の病斑出現状態を無処理と比較調査し、防除効果を求めた。
 以下に示す化合物をそれぞれ含有する薬液について、前記試験を行った。いずれの化合物も防除価が75%以上であった。
 1-2、1-65、1-91、および1-92。
(Test Example 9) Wheat red rust control test The emulsion described in Test Example 7 was diluted with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration was 100 ppm. Prepared. Subsequently, the chemical solution was sprayed on wheat seedlings grown in an unglazed pot (variety “Noribayashi No. 61”, 1.0 to 1.2 leaf stage).
After air-drying the leaves, summer spores of wheat red rust fungus (Puccinia recondita) were shaken off and inoculated, and wheat seedlings were kept in a 22-25 ° C. greenhouse for 10 days. The lesion appearance state on the leaf was compared with no treatment, and the control effect was obtained.
The said test was done about the chemical | medical solution which respectively contains the compound shown below. All the compounds had a control value of 75% or more.
1-2, 1-65, 1-91, and 1-92.
(試験例10) トマト疫病防除試験
 試験例7に記載の乳剤を化合物濃度が100ppmになるように、0.01%のポリオキシエチレンソルビタンモノラウレートを含有する水で希釈して、薬液を調製した。続いて、薬液を、素焼きポットで栽培したトマト幼苗(品種「レジナ」、4~5葉期)に散布した。
葉を風乾させた後、トマト疫病菌(Phytophthora  infestans)の遊走子嚢懸濁液を噴霧接種し、明暗を12時間毎に繰り返す20℃、高湿度の恒温室で4日間保持した。葉上の病斑出現状態を無処理と比較調査し、防除効果を求めた。
化合物番号1-6の化合物を含有する薬液について、前記試験を行った。本化合物は、75%以上の防除価を示した。
(Test Example 10) Tomato plague control test The drug solution was prepared by diluting the emulsion described in Test Example 7 with water containing 0.01% polyoxyethylene sorbitan monolaurate so that the compound concentration was 100 ppm. did. Subsequently, the chemical solution was sprayed on tomato seedlings (variety “Regina”, 4-5 leaf stage) grown in an unglazed pot.
The leaves were air-dried and then sprayed with a zoospore suspension of Phytophthora infestans, and kept in a temperature-controlled room at 20 ° C. and high humidity for 4 days, repeating light and dark every 12 hours. The lesion appearance state on the leaf was compared with no treatment, and the control effect was obtained.
The above test was conducted on a chemical solution containing the compound No. 1-6. This compound exhibited a control value of 75% or more.
 殺虫活性および/または殺ダニ活性に優れ、安全性に優れ、且つ工業的に有利に合成できるアゾリルオキシム化合物またはその塩、ならびにこれを有効成分として含有する有害生物防除剤を提供することができる。 It is possible to provide an azolyl oxime compound or a salt thereof, which is excellent in insecticidal activity and / or acaricidal activity, excellent in safety and can be synthesized industrially advantageously, and a pest control agent containing this as an active ingredient.

Claims (8)

  1.  式(I)で表されるアゾリルオキシム化合物またはその塩。
    Figure JPOXMLDOC01-appb-C000001
    [式(I)中、Hetは、2~3個の窒素原子を環の構成原子として含む6員ヘテロアリール環を示す。
     X1は、Het上の置換基であって、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC2~6アルケニルオキシ基、無置換のもしくは置換基を有するC2~6アルキニルオキシ基、無置換のもしくは置換基を有するC3~8シクロアルキルオキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するC1~6アルキルカルバモイル基、無置換のもしくは置換基を有するアミノ基、メルカプト基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルフィニル基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、無置換のもしくは置換基を有するC6~10アリールオキシ基、ハロゲノ基、シアノ基、またはニトロ基を示す。
     mは、X1の個数を示しかつ0~3のいずれかの整数である。mが2以上のときX1は互いに同一でも異なっていてもよい。
     Aは、炭素原子または窒素原子を示す。
     X2は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するC1~7アシル基、無置換のもしくは置換基を有するC1~6アルコキシカルボニル基、無置換のもしくは置換基を有するアミノ基、メルカプト基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、無置換のもしくは置換基を有するC6~10アリール基、無置換のもしくは置換基を有する3~6員ヘテロシクリル基、ハロゲノ基、シアノ基、またはニトロ基を示す。
     nは、X2の個数を示しかつ0~3のいずれかの整数である。nが2以上のときX2は互いに同一でも異なっていてもよい。
     R1は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、無置換のもしくは置換基を有するC6~10アリール基、または無置換のもしくは置換基を有する3~6員ヘテロシクリル基を示す。
     式(I)中、交差した実線で表した結合は、立体異性を有する二重結合を示す。]
    An azolyl oxime compound represented by the formula (I) or a salt thereof.
    Figure JPOXMLDOC01-appb-C000001
    [In the formula (I), Het represents a 6-membered heteroaryl ring containing 2 to 3 nitrogen atoms as constituent atoms of the ring.
    X 1 is a substituent on Het, which is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2 -6 alkynyl group, unsubstituted or substituted C3-8 cycloalkyl group, hydroxy group, unsubstituted or substituted C1-6 alkoxy group, unsubstituted or substituted C2-6 alkenyloxy Group, unsubstituted or substituted C2-6 alkynyloxy group, unsubstituted or substituted C3-8 cycloalkyloxy group, unsubstituted or substituted C1-7 acyl group, unsubstituted Or a substituted C1-6 alkoxycarbonyl group, an unsubstituted or substituted C1-6 alkylcarbamoyl group, unsubstituted Or a substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1 ~ 6 alkylsulfonyl group, unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl group, unsubstituted or substituted C6-10 aryloxy group, halogeno A group, a cyano group, or a nitro group;
    m represents the number of X 1 and is an integer from 0 to 3. When m is 2 or more, X 1 may be the same as or different from each other.
    A represents a carbon atom or a nitrogen atom.
    X 2 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted C1-7 acyl group, an unsubstituted or substituted group A C1-6 alkoxycarbonyl group, an unsubstituted or substituted amino group, a mercapto group, an unsubstituted or substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfonyl group, Unsubstituted or substituted C6-10 aryl group, unsubstituted or substituted 3-6 membered heterocyclyl Shows a halogeno group, a cyano group or a nitro group.
    n represents the number of X 2 and is an integer from 0 to 3. When n is 2 or more, X 2 may be the same as or different from each other.
    R 1 is an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 alkynyl group, unsubstituted or A substituted C3-8 cycloalkyl group, an unsubstituted or substituted C6-10 aryl group, or an unsubstituted or substituted 3-6 membered heterocyclyl group is shown.
    In the formula (I), a bond represented by crossed solid lines represents a double bond having stereoisomerism. ]
  2.  mが、1、2、又は3のいずれかの整数である請求項1に記載のアゾリルオキシム化合物またはその塩。 2. The azolyl oxime compound or a salt thereof according to claim 1, wherein m is an integer of any one of 1, 2, or 3.
  3.  前記式(I)が、式(II)で表される、請求項1に記載のアゾリルオキシム化合物またはその塩。
    Figure JPOXMLDOC01-appb-C000002
    [式(II)中、X11は、無置換のもしくは置換基を有するC1~6アルキル基、無置換のもしくは置換基を有するC2~6アルケニル基、無置換のもしくは置換基を有するC2~6アルキニル基、無置換のもしくは置換基を有するC3~8シクロアルキル基、ヒドロキシ基、無置換のもしくは置換基を有するC1~6アルコキシ基、無置換のもしくは置換基を有するアミノ基、無置換のもしくは置換基を有するC1~6アルキルチオ基、無置換のもしくは置換基を有するC1~6アルキルスルフィニル基、無置換のもしくは置換基を有するC1~6アルキルスルホニル基、ハロゲノ基、シアノ基、またはニトロ基を示す。
     m1は、X11の個数を示しかつ0~2のいずれかの整数である。m1が2以上のときX11は互いに同一でも異なっていてもよい。
    1、A、X2、n、R1、および交差した実線で表した結合は、前記のとおりである。]
    The azolyl oxime compound or a salt thereof according to claim 1, wherein the formula (I) is represented by the formula (II).
    Figure JPOXMLDOC01-appb-C000002
    [In the formula (II), X 11 represents an unsubstituted or substituted C1-6 alkyl group, an unsubstituted or substituted C2-6 alkenyl group, an unsubstituted or substituted C2-6 An alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, a hydroxy group, an unsubstituted or substituted C1-6 alkoxy group, an unsubstituted or substituted amino group, an unsubstituted or A substituted C1-6 alkylthio group, an unsubstituted or substituted C1-6 alkylsulfinyl group, an unsubstituted or substituted C1-6 alkylsulfonyl group, a halogeno group, a cyano group, or a nitro group. Show.
    m1 represents the number of X 11 and is an integer from 0 to 2. When m1 is 2 or more, X 11 may be the same as or different from each other.
    The bonds represented by X 1 , A, X 2 , n, R 1 and the crossed solid line are as described above. ]
  4.  式(III)で表されるアゾリルオキシム化合物またはその塩。
    Figure JPOXMLDOC01-appb-C000003
    [式(III)中、X1、X11、m1、A、X2、n、R1、および交差した実線で表した結合は、前記のとおりである。]
    An azolyl oxime compound represented by the formula (III) or a salt thereof.
    Figure JPOXMLDOC01-appb-C000003
    [In formula (III), X 1 , X 11 , m 1, A, X 2 , n, R 1 and the bond represented by the crossed solid line are as described above. ]
  5.  請求項1~4のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する有害生物防除剤。 A pest control agent comprising as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of claims 1 to 4 and a salt thereof.
  6.  請求項1~4のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺虫剤または殺ダニ剤。 An insecticide or acaricide containing, as an active ingredient, at least one selected from the group consisting of the azolyloxime compound according to any one of claims 1 to 4 and a salt thereof.
  7.  請求項1~4のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺菌剤。 A fungicide containing as an active ingredient at least one selected from the group consisting of the azolyloxime compound according to any one of claims 1 to 4 and a salt thereof.
  8.  請求項1~4のいずれか一項に記載のアゾリルオキシム化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する外部寄生虫防除剤。 An ectoparasite control agent comprising, as an active ingredient, at least one selected from the group consisting of the azolyloxime compound according to any one of claims 1 to 4 and a salt thereof.
PCT/JP2014/051486 2013-01-28 2014-01-24 Azolyl oxime compound or salt thereof, pest-control agent, insecticide or acaricide, disinfectant, and external parasite control agent WO2014115834A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013-012989 2013-01-28
JP2013012989 2013-01-28

Publications (1)

Publication Number Publication Date
WO2014115834A1 true WO2014115834A1 (en) 2014-07-31

Family

ID=51227623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/051486 WO2014115834A1 (en) 2013-01-28 2014-01-24 Azolyl oxime compound or salt thereof, pest-control agent, insecticide or acaricide, disinfectant, and external parasite control agent

Country Status (2)

Country Link
JP (1) JP2014159413A (en)
WO (1) WO2014115834A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI652074B (en) * 2016-08-09 2019-03-01 大日本除蟲菊股份有限公司 Anti-mold agent composition, anti-mold spray product and anti-mildew method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0368559A (en) * 1989-08-09 1991-03-25 Kumiai Chem Ind Co Ltd Oxime derivative and insecticide
WO2008006874A1 (en) * 2006-07-13 2008-01-17 Bayer Cropscience Sa Fungicide hydroximoyl-tetrazole derivatives
WO2009130193A1 (en) * 2008-04-22 2009-10-29 Bayer Cropscience Sa Fungicide hydroximoyl-heterocycles derivatives
JP2010138166A (en) * 2008-11-17 2010-06-24 Ishihara Sangyo Kaisha Ltd New pyridine derivative or salt thereof, pest-controlling agent containing the same, and method for producing the same
JP2011012088A (en) * 2010-08-10 2011-01-20 Nippon Soda Co Ltd Oxime compound or salt thereof, and fungicide

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0368559A (en) * 1989-08-09 1991-03-25 Kumiai Chem Ind Co Ltd Oxime derivative and insecticide
WO2008006874A1 (en) * 2006-07-13 2008-01-17 Bayer Cropscience Sa Fungicide hydroximoyl-tetrazole derivatives
WO2009130193A1 (en) * 2008-04-22 2009-10-29 Bayer Cropscience Sa Fungicide hydroximoyl-heterocycles derivatives
JP2010138166A (en) * 2008-11-17 2010-06-24 Ishihara Sangyo Kaisha Ltd New pyridine derivative or salt thereof, pest-controlling agent containing the same, and method for producing the same
JP2011012088A (en) * 2010-08-10 2011-01-20 Nippon Soda Co Ltd Oxime compound or salt thereof, and fungicide

Also Published As

Publication number Publication date
JP2014159413A (en) 2014-09-04

Similar Documents

Publication Publication Date Title
JP4789101B2 (en) Herbicidal composition
JP6884251B2 (en) Diarylazole compounds and pest control agents
JP6865873B2 (en) Diarylimidazole compounds and pest control agents
CN109689630B (en) Diaryl azole compound and pest control agent
JP2021008403A (en) 1,3,5,6-TETRA-SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND AGRICULTURAL/HORTICULTURAL FUNGICIDE
JP6837052B2 (en) Pyridine compounds and their uses
JP6508540B2 (en) Pyridine compound and use thereof
JP2017160124A (en) Aryloxy compound and pest control agent
JP2021028298A (en) 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound, and agricultural and horticultural fungicide
MX2011005158A (en) Pyridine derivative or its salt, pesticide containing it and process for its production.
WO2016039048A1 (en) Pyridine compound and use thereof
WO2014065209A1 (en) Pyridine compound or salt thereof, pest control agent, insecticide or acaricide, and ectoparasite control agent
JP4409944B2 (en) Difluoroalkene derivative, pest control agent containing the same, and production intermediate thereof
WO2014115834A1 (en) Azolyl oxime compound or salt thereof, pest-control agent, insecticide or acaricide, disinfectant, and external parasite control agent
JP2016030742A (en) Azolyloxime compound, and pest control agent, insecticide or miticide, sterilization agent, and ectoparasite control agent comprising the same as active ingredient
WO2020175491A1 (en) Pyridine n-oxide compound and pest control agent
JPWO2019176791A1 (en) Heteroarylpyrimidine compounds and pest control agents
JP2019163223A (en) 1,3,5,6-TETRASUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL BACTERICIDE
JP2017078025A (en) Heteroaryl compound and use therefor
WO2020255946A1 (en) 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural and horticultural bactericide
TW201934545A (en) Novel anthranilamides, their use as insecticide and processes for preparing the same
JP2022035834A (en) 2,4-dioxo-1,4-dihydrothienopyrimidine compound and bactericide for agricultural and horticultural use
JP2020045292A (en) Piperidin derivative or salt thereof, and bactericide for agricultural and horticultural use containing the same as an active ingredient
WO2003086077A1 (en) Compositions for animal tick or flea control
WO2015147022A1 (en) Isoxazolin-5-carboxamide compound and pesticide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14743480

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14743480

Country of ref document: EP

Kind code of ref document: A1